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Abstract: This review gives an overview on the development of research on spider venoms with a focus
on structure and function of venom components and techniques of analysis. Major venom component
groups are small molecular mass compounds, antimicrobial (also called cytolytic, or cationic) peptides
(only in some spider families), cysteine-rich (neurotoxic) peptides, and enzymes and proteins.
Cysteine-rich peptides are reviewed with respect to various structural motifs, their targets (ion
channels, membrane receptors), nomenclature, and molecular binding. We further describe the latest
findings concerning the maturation of antimicrobial, and cysteine-rich peptides that are in most known
cases expressed as propeptide-containing precursors. Today, venom research, increasingly employs
transcriptomic and mass spectrometric techniques. Pros and cons of venom gland transcriptome
analysis with Sanger, 454, and Illumina sequencing are discussed and an overview on so far published
transcriptome studies is given. In this respect, we also discuss the only recently described cross
contamination arising from multiplexing in Illumina sequencing and its possible impacts on venom
studies. High throughput mass spectrometric analysis of venom proteomes (bottom-up, top-down)
are reviewed.
Keywords: neurotoxins; proteomics; venomics; transcriptomics; mass spectrometry; bioinformatics;
Araneae; spiders
Key Contribution: This review combines functional and structural aspects of spider venom
components with the analytic possibilities given by rapidly developing DNA sequencing techniques,
mass spectrometry, and bioinformatics.
1. Introduction
Many animal lineages independently developed toxic secretions. Such secretions can be either
deployed through direct contact or ingestion (poison), or through a wound by stingers, teeth, fangs,
harpoons, or other specialized tools (venoms) [1]. While poison is predominantly used as chemical
deterrent to predation, venom is used to fight competitors or aggressors, and/or for predation.
Possession of venom can thereby provide a possibility to subdue a prey without getting involved
in a potentially dangerous fight [1]. Venoms contain dozens of different toxins, many of which
acting as neurotoxins by targeting ion channels and receptors at membranes of excitable cells [2].
Some venomous animals pose a serious threat to primates. Among them, snakes have probably been
the first predators of higher mammals (Placentalia) and have promoted the development of visual
systems and fear in primates [3,4]. Potential threats to primates is also seen as the main reason for the
long-lasting fascination of humans towards venomous animals [5].
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Already long time ago, humans started to use animal venoms for their benefit. Native Americans,
for example, applied rattle-snake venom to the tips of their arrows to increase the damage caused by a
strake [6], and in Ayurveda, a historical Indian medicine, cobra venom was used to treat arthritis [7].
Today, more than ever, venoms are recognized as rich source for development of pharmaceuticals
and venom research is mainly driven by screenings for possible drug leads [8]. Multiple drugs
have been developed from venoms. Among them are an analgesic from a cone snail neurotoxin [9]
and an antihypertensive from a snake venom angiotensin-converting-enzyme inhibitor [10]. Venom
components are also increasingly used in research of their biological targets (e.g., ion channels) [11],
and venoms of imminent danger to humans are studied for development of envenoming therapies [12].
Also, venoms of animals preying on insects are studied for development of insecticides [13].
Besides snakes and some marine animals, commonly known venomous animals especially
comprise arthropods, such as scorpions, various insects, and spiders. Spiders are after insects the
largest taxonomic group of terrestrial organisms and occupy most ecological niches of our planet [14].
Spider venom has for a long time received only small attention due to its limited impact on human
health. Research only gained in focus after realizing the huge pharmaceutical potential of spider
venom peptides [15].
After a long period dominated by Edman degradation, new DNA sequencing techniques and soft
ionization techniques for mass spectrometry (matrix-assisted laser desorption/ionization (MALDI),
and electrospray ionization (ESI)) accelerated also spider venom research. Meanwhile, dozens of venom
gland cDNA libraries, sequenced by Sanger, Roche 454 and Illumina techniques [16–24] diversified our
knowledge on spider venom within less than two decades considerably. Here we review the state of
the art of the composition of spider venoms and the currently available methods to analyze it.
2. Spider Venom Composition
2.1. Spider Venom
Venom is produced in specialized venom glands. Such glands are already present in the oldest
taxon of spiders, the Mesothelae, which developed about 300 million years ago [25,26]. During the
evolution of spiders, the venom glands and venom delivery systems evolved from the very small
and hardly functional glands of Mesothelae to well-developed glands located in the basal cheliceral
segment of mygalomorph spiders (“tarantulas”). With the separation and evolvement of araneomorph
spiders (“true spiders”), the venom glands relocated into the prosoma, where they could occupy more
space, and gained in size [14]. Together with the relocation of the venom gland, also the orientation
of the chelicerae changed from orthognath (fangs face straight down) in mygalomorph spiders to
labidognath (fangs directed towards each other) in araneomorph spiders [27]. This change is reflected
in the older name for these spider groups, Orthognatha and Labidognatha, respectively. The relocation
of the venom gland and reorientation of the chelicerae enabled a reduction in body size without major
impact on a spider’s defensive and attacking power. The reduction in body size was a prerequisite for
the use of functional webs, especially aerial webs, which have developed in several lineages. Today
over 90% of all known spiders are araneomorph and among them 45–50% build webs [14].
Independently from their ability to build a web or not, the use of venom for hunting and defense
seems to be a story of success for spiders. Loss or reduction of venom glands is only described for
spiders of the family Uloboridae, which instead intensively wrap their prey in cribellate silk [28]. Not a
loss, but a partial refunctionalization of the venom gland is observed for spitting spiders (Scytodidae).
In addition to venom, their venom glands produce a protein-based glue that is spit onto a prey from a
distance of approx. 2 cm and leads to immediate immobilization [29].
Most spiders are polyphagous and naturally prey on invertebrates, mainly insects [14].
Specialization on one type of prey is rare and restricted to a few spider taxa: specialization on
ants has been reported for many Zodarion species (Zodariidae) [30], Ammoxenus species (Ammoxenidae)
feed exclusively on termites [31], Ero species and other mimetids (Mimetidae) as well as Portia species
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(Salticidae) prey only on spiders, spiders of the genera Celaenia and Mastophora (Araneidae) are highly
specialized moth predators [32], and Bagheera kiplingi (Salticidae) is the only spider that predominantly
feeds on plants [33]. To what extend a specialization on one type of prey affects the composition of
the venom is largely uninvestigated in spiders. However, a certain heterogeneity between venoms of
individuals of the same species depending on age, gender, or geographic location has been reported
and supports a possible adaptation of the venom composition [34,35]. Adaptive evolution of venom
components on prey is described for other venomous animals, such as snakes [36–38], and cone
snails [39,40].
Spider venom is efficient against a broad spectrum of prey groups, its effect on humans, however,
is largely overestimated. Bites with serious effects are limited to a few spider taxa only, including
the mygalomorph Australian funnel-web spiders (Atrax sp. and Hadronyche sp., Atracidae), and the
araneomorph recluse spiders (Loxosceles sp., Sicariidae), widow spiders (Latrodectus sp., Theridiidae),
and armed spiders (Phoneutria sp., Ctenidae) [41]. The low impact on humans is also reflected in the
number of recorded deaths per year. This is estimated to be less than 5 deaths per year worldwide [42].
Comparatively, 180 fatalities were recorded from scorpion stings [43] and over 125,000 fatalities per
year were reported for snake bites [44]. Reasons for the low number of spider related fatalities in
humans are that (1) >85% of all spider species are <15 mm body length and produce only a very small
quantity of venom (usually <10 µL per pair of venom glands), (2) most taxa are not aggressive, (3) most
spiders do not have mouthparts powerful enough or chelicerae long enough to penetrate the human
skin [45], and most importantly, (4) humans are no prey for spiders, thus, evolutionary distant from a
typical spiders’ prey, which the venom is optimized on.
The toxicity on humans is also directly influencing the research on venom. The knowledge on
venom components was for a long time largely restricted to spiders with medical importance to humans
or to spiders with relatively large body sizes, making them easy to handle. The ArachnoServer [46,47],
a spider specific toxin database, only lists 1561 entries from 100 species (as of 15 May 2019), while
48,389 spider species are described to exist in the World Spider Catalogue [48]. This relatively low rate
of knowledge, in combination with the high diversity in knowledge-depth on single venoms or venom
component groups, makes it challenging to provide a comprehensive overview on spider venom.
In general, the spider venom of a given species is a mixture of over hundred components acting
on different targets including various receptors, mostly located in the muscular or nervous system,
cell membranes, and extracellular matrix. Although single components may be toxic, it is the synergistic
action between the components, which deploys the full toxicity of the venom. The peptide and protein
concentration of spider venom is often relatively high with reports reaching from 65 µg/µL [49] to
150 µg/µL [50]. It is evident, that production of a fluid with these amounts of peptides/proteins
comes at high energetic costs for the spider. Hereof some spiders have been shown to economically
use their venom by adaptation of the injected amounts depending on prey size and movement [51]
or endangerment by the prey [52], a venom usage strategy described by the venom optimization
hypothesis [53].
Spiders produce their venom components in specialized secretory cells in the venom gland.
The venom gland is surrounded by muscular layers controlling venom release by squeezing the
venom gland [54]. Depending on the spider species, venom is released into the glandular lumen
by disintegration of entire cells (holocrine secretion) or by pinch off of parts of cells to form
extracellular membrane-bound vesicles and release of venom components from these vesicles (apocrine
secretion) [54–56].
Spider venom components are typically divided into four groups. (1) Small molecular mass
compounds (SMMSs), (2) antimicrobial peptides (only a few spider families), (3) peptide neurotoxins,
and (4) proteins and enzymes. Details on the different groups of venom components are given in the
following sections.
Toxins 2019, 11, 611 4 of 44
2.2. Small Molecular Mass Compounds
Small molecular mass compounds (SMMCs) are thought to be present in most spider venoms.
They include ions, organic acids, nucleotides, nucleosides, amino acids, amines, and polyamines [14].
Many SMMCs are only marginally investigated compared to venom peptides and systematic studies
are rare. The here presented data and many generally valid conclusions on spider venom SMMCs are
mostly derived from only a few investigations of venoms of selected species.
Venoms of the spider Cupiennius salei (classically listed as Ctenidae, recently moved to Trechaleidae)
and Aphonopelma hentzi (published as Eurypelma californicum) (Theraphosidae) are rich in potassium
(approx. 200 mM, and 70 mM, respectively) and poor in sodium (approx. 10 mM) [50,57]. These cation
concentrations are opposite to the hemolymph concentrations. The high potassium content of venom
is described to induce depolarization of excitable cell membranes, leading to paralysis of the prey,
and to synergistically enhance the activity of venom peptides [58,59].
Spider venom has an acidic pH with pH values reported between 5.3 and 6.1. Main contributors
to this acidic environment are organic acids, primarily citric acid, which is by far the most described
organic acid present in spider venom [14]. Citric acid is also present in snake, scorpion, bee, wasp,
and ant venoms and was proposed to reversibly inhibit divalent cation dependent enzymes (e.g.,
phospholipase A2 or metallopeptidases) in the venom gland by complexation of Ca2+ and Zn2+. After
venom injection, dilution of citric acid would shift the equilibrium in direction of complexation of the
cations by the venom enzymes. The enzymes would thereby get reactivated [60].
Many SMMCs effect neuronal or neuromuscular signal transduction. Nucleosides (some with
sulfate-ester) are known from many spider venoms and have been reported to block kininate receptors
and L-type Ca2+ channels [61]. Nucleosides are a major component of the venom of Loxosceles sp. [62]
and they even make up to 50% of the venom dry weight in Tegenaria sp. [63].
Acylpolyamines are a diverse class of molecules built from an aromatic acyl group and a
polyamine backbone (some with amino acids in the backbone). They possess masses ranging from 350
to 1000 Da and are described to plug open ionotropic glutamate receptors and to induce paralysis in a
prey item [42,64]. Amino acid-containing acylpolyamines are described for Araneidae, non-amino
acid-containing for Agelenidae, Amaurobiidae, and Pisauridae (all araneomorph) and Ctenizidae,
Theraphosidae, and Atracidae (mygalomorph). Glutamate receptors are also blocked by polyamines
not containing an acyl group (e.g., spermidine, spermine) reported from the venom of some spiders [65].
Other SMMCs reported form spider venom act as neurotransmitter in invertebrates. Among them
GABA, glutamate, acetylcholine, adrenaline, and biogenic amines, such as noradrenaline, histamine,
octopamine, tyramine, serotonin, and dopamine [14,42,66,67]. Further SMMCs include all proteinogenic
amino acids, the non-proteinogenic amino acid taurine, and nucleotides [14].
2.3. Antimicrobial Peptides
Antimicrobial peptides (AMPs) are also termed cytolytic or cationic peptides. AMPs often
feature high positive net charges and a high number of hydrophobic amino acids. They are widely
distributed as major components of animal immune systems and are also present in various arthropod
venoms, such as ant, scorpion, bee, and wasp venoms [68,69]. AMPs disrupt the integrity of cellular
membranes. They are attracted to the surface of cellular membranes owing to interaction of their
positively charged amino acid side chains with negatively charged head groups of phospholipids or
other negatively charged surface molecules. In proximity to membranes, AMPs exhibit an amphipathic
α-helical structure. This amphipathic structure facilitates the insertion of AMPs into the cell membrane.
Positively charged parts of the α-helix interact with negatively charged phospholipid head groups and
hydrophobic parts of the α-helix with phospholipid tails (Figure 1A).
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neutral. 
Multiple models for the membranolytic activity of AMPs have been proposed (Figure 2B). In the 
barrel pore model, multiple AMPs oligomerize and insert perpendicularly into the membrane, form-
ing a pore where the hydrophilic region of the α-helices face the center of the pore. The toroidal pore 
model is similar to the barrel pore model but assumes that pore-forming AMPs always interact with 
lipid head groups. In the carpet model, AMPs coat parts of membranes leading to peptide-micelle 
formation and formation of holes in the membrane [71]. The efficiency of the membranolytic effect 
may be influenced by the lipid composition of cellular membranes and the membrane potential. 
Cupiennins (AMPs from the venom of the spider Cupiennius salei) have been reported to strongly 
interact with negatively charged 1-palmitoyl-2-oleoyl phosphatidyl-DL-glycerol vesicles, but only 
weakly with zwitterionic 1-Palmitoyl-2-oleoyl phosphatidylcholine vesicles [72]. Oxyopinins (from 
Oxyopes takobius, erroneously identified as O. kitabensis) more efficiently lyse phosphatidylcholine 
(zwitterionic) vesicles than phosphatidylethanolamine (zwitterionic) or phosphatidic acid (negative) 
vesicles [73]. Phospholipid headgroup size and related membrane density and fluidity have also been 
named as possible influencers of the cytolytic efficiency [73]. In addition, latracins (Lachesana tara-
baevi) only act on membranes with a negative potential, resembling the potential of living cells (>−100 
mV), but not on membranes with a positive potential [74]. The efficiency of the cytolytic activity may 
also be influenced by molecules exposed on the surface of membranes, such as sialic acid, which was 
shown to promote binding and hemolytic activity of a cupiennin 1a analogue (Cupiennius salei) [75]. 
AMPs have so far only been reported to occur in venoms of Cupiennius salei and the spider fam-
ilies Zodariidae, Lycosidae, and Oxyopidae [14]. Spider venom AMPs feature masses between 2–5 
kDa and are, in most cases, cysteine free peptides. It is not unusual, that they contain a glycine or 
proline residue, inducing a hinge in their α-helical structure. Two representatives of spider venom 
AMPs are shown in Figure 1C.  
Some spider venom AMPs are supposed to act according to the toroidal pore model [76–78], 
others according to the carpet model [74,79] (Figure 1B). In addition, Corzo et al. [73] hypothesized, 
that the mechanism of action may depend on the type (zwitterionic or anionic) of lipids, the target 
membrane is composed of. Besides the membranolytic activity of AMPs, activities including the in-
hibition of the neuronal nitric oxide synthase [80] and of the superoxide producing NADPH oxidase 
Figure 1. Antimicrobial peptides (AMPs) and their proposed mechanism of action. (A) Model of
interaction between an AMP and phospholipids. AMPs assume an amphipathic α-helical structure
in proximity to cellular membranes. The hydrophobic side of the helix (white) inserts into the
membrane and interacts with the phospholipid side chains. The positively charged side (blue) interacts
with negatively charged lipid head groups. (B) Models of membranolytic actions of AMPs. (C)
NMR-based 3D structures of two antimicrobial peptides from spider venom. Electrostatics were
computed using PDB2PQR [70]. Blue surfaces represent positively charged surfaces; red negative
charged; and white neutral.
Multiple models for the membranolytic activity of AMPs have been proposed (Figure 2B). In the
barrel pore model, multiple AMPs oligomerize and insert perpendicularly into the membrane, forming
a pore where the hydrophilic region of the α-helices face the center of the pore. The toroidal pore
model is similar to the barrel pore model but assumes that pore-forming AMPs always interact with
lipid head groups. In the carpet model, AMPs coat parts of membranes leading to peptide-micelle
formation and formation of holes in the membrane [71]. The efficiency of the membranolytic effect
may be influenced by the lipid composition of cellular membranes and the membrane potential.
Cupiennins (AMPs from the venom of the spider Cupiennius salei) have been reported to strongly
interact with negatively charged 1-palmitoyl-2-oleoyl phosphatidyl-DL-glycerol vesicles, but only
weakly with zwitterionic 1-Palmitoyl-2-oleoyl phosphatidylcholine vesicles [72]. Oxyopinins (from
Oxyopes takobius, erroneously identified as O. kitabensis) more efficiently lyse phosphatidylcholine
(zwitterionic) vesicles than phosphatidylethanolamine (zwitterionic) or phosphatidic acid (negative)
vesicles [73]. Phospholipid headgroup size and related membrane density and fluidity have also been
named as possible influencers of the cytolytic efficiency [73]. In addition, latracins (Lachesana tarabaevi)
only act on membranes with a negative potential, resembling the potential of living cells (>−100 mV),
but not on membranes with a positive potential [74]. The efficiency of the cytolytic activity may also be
influenced by molecules exposed on the surface of membranes, such as sialic acid, which was shown
to promote binding and hemolytic activity of a cupiennin 1a analogue (Cupiennius salei) [75].
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AMPs have so far only been reported to occur in venoms of Cupiennius salei and the spider families
Zodariidae, Lycosidae, and Oxyopidae [14]. Spider venom AMPs feature masses between 2–5 kDa
and are, in most cases, cysteine free peptides. It is not unusual, that they contain a glycine or proline
residue, inducing a hinge in their α-helical structure. Two representatives of spider venom AMPs are
shown in Figure 1C.
Some spider venom AMPs are supposed to act according to the toroidal pore model [76–78], others
according to the carpet model [74,79] (Figure 1B). In addition, Corzo et al. [73] hypothesized, that the
mechanism of action may depend on the type (zwitterionic or anionic) of lipids, the target membrane
is composed of. Besides the membranolytic activity of AMPs, activities including the inhibition of the
neuronal nitric oxide synthase [80] and of the superoxide producing NADPH oxidase [75] have been
reported for single peptides. Other hypothesized functions include antimicrobial defense of gland and
delivery system [69], or, controversially discussed, the pre-digestion of prey [14,81]. AMPs of the spiders
Cupiennius salei and Oxyopes takobius have been shown to synergistically act with neurotoxins [52,58,73].
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It has been proposed that AMPs facilitate the movement and access of neurotoxins to their targets [58].
The exact mechanism of the synergistic action, however, remains uninvestigated.
2.4. Cysteine-Rich Peptides
Cysteine-rich peptides are the best investigated venom components and are believed to exist in
most spider venoms [14]. Spider venoms typically contain dozens of different cysteine-rich peptides,
whereof most are thought to act on channels and receptors on membranes of excitable cells. That is why
they are often referred to as neurotoxic peptides or neurotoxin-like peptides. Cysteine-rich peptides
typically have molecular masses between 3 and 9 kDa, and feature ≥6 cysteine residues in conserved
structural motifs [14].
2.4.1. Structural Motifs
The most prominent structural motif of spider venom cysteine-rich peptides is the inhibitor cystine
knot (ICK) motif. A number of other structural motifs are less frequently found in spider venom
peptides. These are (1) the disulphide-directed β-hairpin (DDH) fold, (2) the Kunitz motif, (3) the
colipase like fold, also known as MIT1-like fold, and (4) the helical arthropod-neuropeptide-derived
(HAND) motif.
The ICK motif was initially characterized by a triple stranded antiparallel β-sheet stabilized by
six cysteines arranged in the disulphide bonds C1–C4, C2–C5, C3–C6. The cystine C3–C6 thereby
penetrates the characteristic ring formed by the two other disulphide bonds and the peptide backbone
(Figure 2A). This cystine structure is often referred to as cystine knot, and peptides featuring this
knot as knottins [82,83]. Meanwhile, some ICK-like peptides have been found to lack the first β-sheet,
but still featuring the β-hairpin formed from the β-sheets 2 and 3 [84]. Many peptides feature the
ICK as core motif but contain additional cysteines. A common variation is the inclusion of a fourth
disulphide bridge in the loop of the β-hairpin between C5 and C6 of the simple ICK motif (e.g., [85]).
Peptides featuring the ICK motif are found in the venom of various organisms besides spiders (e.g.,
scorpions [86], and cone snails [87]), but also in peptides with different functions, such as protease
inhibitors of plants [88], an immunopeptide from horseshoe crabs [89], or an elicitor protein of a fungal
tomato pathogen [90].
The DDH fold (Figure 2B) is widely distributed among different organisms [84]. It features two
mandatory disulphide bonds (C1–C3, C2–C4) and an antiparallel β-hairpin, comparable with the
β-hairpin formed by the beta sheets 2 and 3 of ICK peptides [14]. The loop before the first β-sheet
(between Cys 2 and Cys 3) commonly comprises a Gly or Pro residue supporting a tight turn of the
peptide backbone [91]. Some scientists considered the DDH as an ancient fold, from which the ICK
fold evolved [91], others suggested, that the DDH is a derivative of the ICK [92]. The Kunitz motif
(Figure 2C) is the active domain of a class of serine protease inhibitors. It usually features an antiparallel
β-sheet and a C-terminal α-helical part constrained by three disulphide bridges (C1–C6, C2–C4, C3–C5).
Venom peptides with this motif were originally isolated from snakes (green mamba) [93] and later also
identified in the venom of other animals including cone snails [94] and sea anemones [95]. Despite
their structural similarity to protease inhibitors, many Kunitz domain containing venom peptides have
been described to block potassium ion channels [96–98]. Some only retained very weak inhibitory
effects on serine proteases [98].
A colipase like fold (Figure 2D) of a venom peptide was first reported for the snake toxin mamba
intestinal toxin 1 (MIT-1) [99,100]. Later, homologues were reported from frog skin [101], humans,
mice [102], and further animals [103]. These peptides commonly comprise the four amino acids AVIT at
their N-terminus. Accordingly, the peptide family is also known as AVIT family [104]. The characteristic
disulphide bridge pattern (C1–C4, C2–C5, C3–C7, C6–C9, C8–C10) is similar to the one of colipases and
the C-terminal region of Dickkopf proteins [104]. This fold has been discussed to conform two head to
tail connected DDH motifs [91]. MIT-1 and its homologue from the skin of the toad Bombina variegata
were shown to bind mammal prokinectin receptors and to cause short term gastric smooth muscle
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contraction and hyperalgesia [101]. Dickkopf-like activities could not be detected [104]. Homologues
in spider venom have first been reported from Australian funnel-web spiders. These peptides, however
lack the N-terminal AVIT domain and they do not bind prokinectin receptors, nor induce contractions
of gastrointestinal smooth muscle, or cause toxic effect on house crickets [105,106]. Related peptides
have meanwhile also been reported in other spiders [107], their function, however, remains unknown.
HAND toxins (Figure 2E) are composed of four tightly packed α-helices stabilized by three
disulphide bridges (C1–C5, C2–C4, C3–C6). Unlike the vast majority of other spider venom peptides,
their precursors do not contain a propeptide. HAND toxins are widespread in araneomorph spiders
(e.g., Nephila sp., Loxosceles sp., Sicarius sp., Heteropoda sp., Latrodectus sp., Tegenaria sp.) and are also
found in centipedes, wasps, ticks, and scorpions [108,109]. They are thought to have convergently
evolved from neuropeptide hormones of the crustacean hyperglycaemic hormone and arthropod ion
transport peptide families [109,110]. The first HAND toxins isolated from spider venom, the latrodectins,
were co-purified with large pore-forming proteins (alpha-latrotoxins) and were thought to act as
co-factors for them [111,112]. Latrodectins were reported to lack toxicity on mice and cockroach [113].
Today, HAND toxins are also known for many spiders, which do not contain alpha-latrotoxin
homologues. Toxic effects are not reported with one exemption: U1-agatoxin-Ta1a (O46166) from
the spider Eratigena agrestis, shows insecticidal activity probably resulting from directly targeting the
insect’s central nervous system (CNS) [114].
Most commonly, spider venom cysteine-rich peptides are monomers. To the best of our
knowledge, there are currently only two heterodimeric structures known (U2-ctenitoxin-Cs1a, P83919,
Cupiennius salei [59], and omega-agatoxin-1A, P15969, Agelenopsis aperta [115]). These two toxins are
further discussed below.
2.4.2. Targets of Neurotoxic Peptides
Neurotoxic peptides modulate a broad range of channels and receptors on membranes of excitable
cells (e.g., nerves and muscles). Their target specificity is thereby not reliably predictable given the
structural motif or the primary sequence of a peptide. Specificities and potency are experimentally
investigated, frequently in patch-clamp experiments, e.g., [116]. Neurotoxic peptides form stable
complexes with channels or receptors and are effective already at nanomolar concentrations. Thus,
neurotoxic peptides exhibit their toxic effects already at concentrations, which are at least one
order of magnitude lower than the one of non-selective toxins, such as AMPs. The toxic effects,
however, can be dependent on the type of prey, the specificity of the neurotoxins for the specific
channels, and the receptors expressed by that prey [14,81]. When counting today (15 May 2019),
481 out of 1561 entries listed in the ArachnoServer have a described target. Of them 46% act on
voltage-activated sodium channels (NaV) of different subtypes by either delaying their inactivation
(e.g., delta-ctenitoxin-Pn2c, O76199), inhibiting their opening (e.g., mu-theraphotoxin-Hs2a_1, P83303),
or shifting their potential limit for activation (e.g., beta-theraphotoxin-Cm1a, P84507). Approx.
37% inhibit voltage gated calcium channels (CaV, e.g., omega-ctenitoxin-Cs1a, P81694), and 15%
inhibit voltage gated potassium channels (KV, e.g., Kunitz-type kappa-PI-theraphotoxin-Hs1a,
P68425). Other targets include acid-sensing ion channels (e.g., pi-theraphotoxin-Pc1a, P60514),
NMDA-glutamate-receptors (e.g., gamma-ctenitoxin-Pn1a, P59367), calcium-activated potassium
channels (e.g., kappa-hexatoxin-Hv1e [sic], S0F1M9), and transient receptor potential (TRP) channel
(e.g., tau-theraphotoxin-Gr1a, M5AXK5). The action of a toxin is not necessarily restricted to one
type of channel (e.g., beta/kappa-theraphotoxin-Hlv1a, B3EWN3; mu/omega-theraphotoxin-Hs1a(1),
B3FIR8). Ion channels on membranes of excitable cells are responsible for proper signal transduction.
Calcium channels are involved in neurotransmitter release from presynaptic cells, voltage gated sodium
channels enable the transport of the action potential along excitable cells, and voltage gated potassium
channels are crucial for restoring a resting state in depolarized cells. Disruption of the channels function
(e.g., by inhibition or non-natural activation through toxins), may affects coordination, locomotion,
respiration, and cardiac functions leading to various symptoms including convulsions, paralysis,
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and death. Toxins acting on the capsaicin receptor (transient receptor potential channel) may induce
inflammatory pain [117,118].
2.4.3. Nomenclature of Toxins
In 2008, King et al. [119] recognized the need of a universal nomenclature for maintaining an
overview on the rising number of known peptides of venomous animals and introduced a rational
nomenclature based on their molecular target. This three-part-nomenclature includes a (1) Greek letter
describing a toxin’s activity or target (e.g., “ω” for CaV blockers, or “U” for unknown), followed by (2)
an indicator of the source organism’s family, genus, and species, (e.g., “ctenitoxin-Cs” for Cupiennius
salei (Ctenidae), and (3) a number to distinguish toxins with identical parts 1 and 2. Examples for
the nomenclature of peptides acting on the most relevant targets for spider venoms are given in
Table 1. The big advantage of this nomenclature is the fast identification of a toxin’s target in its
name. This, however, is only possible, if the target is known and the ArachnoServer lists currently (15
May 2019) 61% of toxins with unknown target. Recent developments in omics techniques resulted
in a flood of toxin sequences with no associated functional data, deposited in online repositories.
For such toxins, the nomenclature is restricted to consecutively numbering the toxins of a spider e.g.,
U1-ctenitoxin-Cs1a, U2-ctenitoxin-Cs1a, U3-ctenitoxin-Cs1a.
Table 1. Activities and nomenclature [119] of main spider venom toxins.
Prefix Target Action Example
ω (omega) CaV channels Inhibits CaV channels omega-agatoxin-1a, P15969
κ (kappa) KV channels Inhibits KV channels kappa-hexatoxin-Hv1c, P82228
β (beta) NaV channels
Shifts voltage
dependence of NaV
channel activation
beta-hexatoxin-Mg1a, P83561
δ (delta) NaV channels
Delays inactivation of
NaV channels
delta-miturgitoxin-Cp1b,
C0HKG8
µ (mu) NaV channels Inhibits NaV channels mu-diguetoxin-Dc1a, P49126
M membrane Membranolytic activity M-ctenitoxin-Cs1a, P83619
U unknown Unknown activity U2-ctenitoxin-Cs1a, P83919
In addition, the linkage of this nomenclature to the spider family, genus, and species names can
lead to confusion caused by taxonomical rearrangements of spiders. As example, Atrax and Hadronyche
species have recently been moved from Hexathelidae to an own family, Atracidae [48]. Consequently,
delta-hexatoxin-Hf1a from Hadronyche formidabilis would require renaming to delta-atracitoxin-Hf1a.
Also, U10-theraphotoxin-Hs1a would require renaming to U10-theraphotoxin-Cs1a because the
theraphosid Haplopelma schmidti has meanwhile been moved into the genus Cyriopagopus.
2.4.4. Molecular Binding of Neurotoxins
Binding of toxins to their receptors is often studied by combination of patch-clamp
electrophysiology with recombinant expression of the toxin and/or receptor and site directed
mutagenesis (e.g., alanine screening), [120–123]. Structural data of toxins (e.g., from NMR spectroscopy)
are often included to study structure activity relationships (SAR). Exceptional insight is also gained
from the only recently published first crystal structures of spider venom toxins bound to their target
channels [124–126].
Most, but not all [127] spider venom neurotoxins are today thought to bind their target channels
indirectly. They first partition into the cellular membrane and then laterally diffuse to reach the target
channel. Hereof, several neurotoxic peptides have been found to bind model membranes and to form
trimolecular complexes consisting of the toxin bound to the membrane and the target receptor [128].
Membrane contact is thought to enhance the affinity of inhibition as a large part of the binding energy
deviates from membrane binding [129]. Furthermore, membrane binding was also shown to induce
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structural changes of a toxin [130], and cause ideal positioning of a toxin to bind voltage-gated ion
channels [131].
Neurotoxin–membrane interaction was extensively studied with VSTx1
(kappa-theraphotoxin-Gr3a, P60980). This tarantula venom toxin induces a thinning of the
phospholipid bilayer and locates superficially at the lipid–water interface inserting several
hydrophobic amino acids into the membrane interior, while basic residues mainly retain in the aqueous
phase [131]. The toxin region interacting with the membrane thereby resembles a hydrophobic
patch surrounded by a ring of positively charged amino acids. This motif is present in many spider
toxins and is generally thought to be important for membrane partitioning (Figure 3A) [128,132,133].
Electrostatic interactions between the ring of positively charged amino acids and lipid head groups
thereby seem to be important for membrane binding as some toxins were found to have a higher
affinity to membranes with high amounts of negatively charged lipids (e.g., phosphatidylglycerols)
than to membranes with zwitterionic lipids (e.g., phosphatidylcholines) [127,132,134,135]. The targets
of most spider venom neurotoxins are voltage-gated sodium, potassium, and calcium channels.
These channels are generally composed of a central pore determining the ion selectivity and four
surrounding voltage-sensing domains regulating opening and closing of the central pore. While most
KV are tetramers, most NaV and CaV are composed of one polypeptide with four repeated similar
domains (1 to 4). Every repeat (or subunit of the KV channel) contains six transmembrane helices
(S1–S6) with S1–S4 forming a voltage sensing domain and S5–S6 forming the central pore. Many
channels also contain an associated regulatory domain at the cytosolic site [136].Toxi s 2019, 11, x FOR PEER REVIEW 10 of 47 
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Figure 3. Binding of neurotoxins to a voltage gated ion channel. Peptides are shown space filling, ion
channels as cartoons with every domain in a different color. (A) Hydrophobic patch with surrounding
ring of charged amino acids. Hydrophobic amino acids are shown in green, negatively charged in blue,
and positively charged in red. (B) Four ProTx-2 toxins bound to the human NaV1.7 channel in side
view. Toxin surface represents surface charge. Eye-icons and arrows indicate the viewing angel in
panels B1 and B2. (B1) View on one voltage-sensing domain of the channel bound to the toxin from the
inner side of the membrane towards outwards. (B2) View on the toxin-channel complex form the top.
Helices of the voltage sensing domain are indicated with S1–S4.
Binding of spider neurotoxins to voltage gated ion channels was predominantly studied for NaV
channels. A recent 3D structure of a toxin-receptor complex is shown in Figure 3B. Most toxins were
shown to bind to the helices S3 and S4 of the voltage sensing domain, allosterically modulating pore
gating [137,138]. This is in contrast to the action of venom acylpolyamines, such as argiotoxin-636
(from Argiope lobata), which inhibits calcium-permeable AMPA receptors by directly inserting into
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the pore [139]. Toxin-channel interaction may also involve domains in proximity to S3 and S4 (e.g.,
S1–S2 loop, and S5), as recently shown for the double ICK peptide Dc1a bound to a mammalian NaV
channel [124]. Binding is often based on interaction of certain residues of the hydrophobic patch
and the surrounding positive charged amino acids with hydrophobic and anionic amino acids of the
target channel (compare Figure 3B1) [128]. A similar toxin surface was also shown to be involved in
binding of the ASIC channel inhibitor PcTx 1 (pi-theraphotoxin-Pc1a, P60514) [140,141]. In contrast
to voltage gated channel modulators, whose binding sites on channels are partially located within
the membrane, PcTx 1, binds 45 Å above the lipid bilayer [140]. Intriguingly, PcTx 1 was anyhow
shown to superficially interact with membranes. It has been proposed, that this interaction may be
advantageous for finding its target channel due to reduction of the dimensions of diffusion [141].
2.4.5. Modular Toxins—Combination of Toxin Structures
Most spider venom toxins can be either classified as “classic” AMP or “classic” neurotoxin-like
peptide. Some toxins, however comprise a multi-domain construction with each domain resembling
the structure of a “classic” spider toxin [142]. Multiple combinations of domains are thereby possible:
neurotoxin-AMP, AMP-neurotoxin, AMP-AMP, and neurotoxin-neurotoxin.
Toxins exhibiting neurotoxic and cytolytic domains and corresponding activities exist in two
forms. The cationic anti-microbial domain may locate C-terminal (e.g., CsTx-1, Cupiennius salei [20];
purotoxin-2, Alopecosa marikovskyi [143]) or N-terminal (spiderines, Oxyopes takobius [142,144]) of the
neurotoxic domain (Figure 4A,B). Multiple assets from the two-domain construction of these toxins
have been suggested. Oparin et al. [143] and Kuhn-Nentwig et al. [145] hypothesized that the α-helical
part of these two-domain toxins binds to the cell membrane, thus increasing the efficiency of binding
of the neurotoxic part to a receptor. Besides such a broader mode of action also an aggravation of the
development of resistance against these two-domain toxins was suggested by Kuhn-Nentwig et al. [20].
The combination of cytolytic and neurotoxic activities of toxins is not restricted to spiders, but was also
reported for scorpions [146].
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(CpTx1–4) [148,149]. CpTx1–4 comprise at least 1/3 of all venom proteins of Cheiracanthium punctorium.
It is likely, that CpTx1–4 additionally contain an α-helical motif C-terminally of the ICKs, making them
similar to two joined neurotoxins with an additional cytolytic domain.
Besides toxins with two neurotoxin-like domains, there are also toxins with two joined cytolytic
domains (Figure 4D): The zodariid Lachesana tarabaevi expresses cyto-insectotoxins comprising two
separated domains with a high propensity to form amphiphilic α-helices in proximity to membranes.
These toxins show increased insecticidal activity compared to “simple” cytolytic peptides of the same
spider [150].
2.5. Enzymes and Proteins
For a long time, enzymes and proteins were assigned a minor role in many spider venoms.
Most publications constrained to enzymes described to target the extracellular matrix or the
membrane of cells, facilitating the movement of toxins in the prey as so-called spreading factors.
These enzymes include hyaluronidases, collagenases, and phospholipases. Hyaluronidases cleave the
1-4-linkages between N-acetylglucosamine and glucoronate in hyaluronan, a key component of the
extracellular matrix. Another key component of the animal extracellular matrix, collagen, is cleaved by
matrix-metalloproteases named collagenases. Phospholipases directly target the cells’ lipid bilayer by
hydrolysis of phospholipids [14]. While many spider venoms contain phospholipase A [14], sicariid
spiders contain extraordinarily high venom concentrations of phospholipase D (also referred to as
sphingomyelinase D) [151]. This enzyme is responsible for necrotic effects in humans and efficiently
immobilizes insects, also due to an additional neurotoxic effect [152].
In recent past, an increasing number of additional spider venom enzymes have been found and
suggest a separation of spider venom proteins into three functional classes. (1) Enzymes acting as
spreading factor (see above), (2) proteins with a function in the venom gland of the spider including
the maturing of toxins (see next chapter), and (3) proteins directly targeting important systems of the
prey organism. Functions of venom proteins, however, are in most cases not experimentally studied,
but only hypothesized based on similarity to known enzymes.
Proteins with a potential function in the venom gland include protein disulphide isomerases [107],
a peptide isomerase [153], carboxypeptidases [107], and the recently identified 28 kDa serine proteases
responsible for propeptide cleavage of immature toxin precursors (see next chapter). Other proteins,
such a leucine-rich repeat domain-containing protein or a tachylectin 5A-like protein, showing similarity
to immune active proteins of spider-related animals, were hypothesized to possibly be involved in
protection of the venom gland against microbial infections [107].
Proteins probably directly targeting important systems in the prey may be large neurotoxic
proteins (see below), an acetylcholinesterase responsible for degradation of the neurotransmitter
acetylcholine at synapses [21], or an α-amylase, hypothesized to cause hyperglycemia in the prey due
to fast release of high amounts of glucose from the prey’s glycogen storages [107].
Proteins with a high similarity to angiotensin-converting enzyme, an exo-metallopeptidase
processing peptide hormones involved in blood pressure regulation of vertebrates, were identified
in various venoms of spiders [107,154,155] and scorpions [156]. These enzymes could be involved in
venom peptide processing or target peptide hormones in the prey [107]. Another group of frequently
described spider venom proteins are cysteine-rich secretory proteins (CRISPs) homologues [21,22,107].
CRISPs belong to the CAP (cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1
proteins) protein superfamily and are widely distributed among animal venoms, e.g., scorpions and
snakes [157], but are also found in mammalian epididymis and the immune system [158]. Many
different functions are described for CRISPs, including involvement in sperm-egg fusion [159] and
immune defense [160] for mammalian CRISPs, or ion channel blocking effects for snake venom
CRISPs [161–163]. In addition, a CAP superfamily saliva protein of blood-sucking insects was
recently described to inhibit platelet aggregation and act as antioxidant enzyme by scavenging of
superoxide [164]. The function of CRISPs in spider venom, however, remains elusive.
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The majority of the here described venom proteins act as enzymes. A notable exception are
latrotoxins, a group of neurotoxic proteins with masses between approx. 110 and 130 kDa initially
reported from widow spiders (Latrodectus species) [165]. Similar toxins were later also reported from
the venom of Steatoda and from genomic data of Parasteatoda (both Theridiidae), but the presence in the
genome does not necessarily imply expression in the venom gland [166–168]. Latrotoxins exert different
specificities, for insects, vertebrates, or crustaceans, and are accordingly named latrotoxins (against
vertebrates), latroinsectotoxins, or latrocrustotoxins. The best studied latrotoxin is alpha-latrotoxin,
which can cause fatalities in vertebrates. The main toxic action of alpha-latrotoxin relies on the
formation of homotetrameric complexes that insert into presynaptic neuronal membranes, forming
cation permeable pores [169,170]. Pore formation leads to massive influx of Ca2+, stimulating
the release of all known types of neurotransmitters from presynaptic cells ultimately leading to
the blockade of signal transmission inducing clinical symptoms such as muscular paralysis [81].
Binding of alpha-latrotoxin to membranes is thought to be mediated through surface proteins. Three
alpha-latrotoxin receptors could so far be identified: Neurexin, latrophilin, and tyrosine phosphatase σ.
Alpha-latrotoxin may also induce neurotransmitter release through a pathway, which is independent
from influx of Ca2+ into the presynaptic cell (for a review see Yan and Wang [171]). Latrotoxins
comprise a common structure featuring an N-terminal part with conserved regions, a central part
containing multiple ankyrin repeats, and a C-terminal propeptide [165]. Ankyrin repeats mediate
protein-protein interactions and are one of the most frequently observed amino acid motifs [172].
Posttranslational removal of the C-terminal propeptide seems to be required to exceed a toxic action as
propeptide containing precursors of δ-latroinsectotoxin from Latrodectus tredecimguttatus have been
shown to be inactive [173].
2.6. Spider Venom Peptide Precursors and Their Maturing
Neurotoxic and cytolytic spider venom peptides are expressed as precursors undergoing proteolytic
cleavage to yield the mature peptide. Precursors of neurotoxic peptides typically comprise three
consecutive parts. (1) A signal peptide, which is removed during translocation through the endoplasmic
reticulum, (2) a propeptide, and (3) the mature toxin. Most propeptides feature lengths between
approx. 6 and 30 amino acids and commonly contain a high number of negatively charged amino
acids often compensating for the overall positive charge of the mature peptide (Figure 5) [107]. It has
been proposed, that this charge compensation is beneficial for the storage of the immature toxin,
as electrostatic repulsion between the precursors is reduced [107]. Propeptides may also assure correct
peptide folding, sorting, and maturation [81] and prosequence elements of AMPs may neutralize their
lytic activity before cleavage [174].
In 2005, Kozlov et al. [17] recognized that the four C-terminal amino acids of the propeptide form
a conserved motif. This motif comprises an arginine residue at position −1 and at least one glutamic
acid residue at positions −2 to −4 before the start of the mature peptide. The motif, named Processing
Quadruplet Motif (PQM), is thought to act as protease recognition site for the propeptide cleaving
protease. Later, a minority of neurotoxic peptide precursors were found to feature a dibasic cleavage
motif (e.g., KR, RR) instead of a PQM, or not to comprise any propeptide [145,175].
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Antimicrobial peptides show a precursor organization comparable to neurotoxic peptides
comprising a signal peptide followed by an acid propeptide and the mature peptide. Besides
these simple precursors, there are also binary or complex precursors, comprising multiple mature
AMPs in a row, separated by short spacer sequences (Figure 5E) [176]. The spacer sequences thereby
contain protease recognition motifs for posttranslational cleavage, allowing release of the individual
AMPs from the long precursor. The recognition motifs are usually a PQM at the C-terminal end of
the spacer and a so-called inverted Processing Quadruplet Motif (iPQM) at the N-terminal site of the
spacer. An iPQM is basically a mirrored PQM comprising an Arg residue at position 1 and at least
one Glu residue at positions 2 to 4. During removal of spacers from the complex precursors, the PQM
is cleaved C-terminally of its Arg-residue in analogy to the propeptide cleavage. iPQM cleavage,
however is proposed to be a two-step processing process, comprising first cleavage C-terminally of
the Arg residue of the iPQM by an endopeptidase, and second, removal of the remaining Arg-residue
by a carboxypeptidase (Figure 5A) [177]. The endopeptidase involved in PQM and iPQM cleavage is
thereby likely to be the same [178].
Expression of AMP-precursors featuring a propeptide has been proposed to be a way for preventing
potential harmful cytolytic actions during the biosynthesis of a toxin. It is believed that the negatively
charged propeptides or spacers thereby interact with the positively charged clusters of the mature
toxin neutralizing its effect before the toxin is activated by the processing into its mature form [74,174].
At which state of venom peptide production the protease-mediated maturing occurs (e.g., before or after
storage in secretory vesicles) remains uninvestigated. However, the existence of heterodimeric toxins
with disulphide linked chains as described below implies a precursor cleavage after the disulphide
bridge formation.
2.6.1. Comparison of Protease Cleavage Motifs to Motifs of Other Organisms
Distinguishing between cleavage motifs can be challenging, as certain sequences may be following
the rule of several described motifs (e.g., EVKR may be classified as dibasic motif and as PQM). Dibasic
cleavage motifs and similar motifs comprising a basic residue at the cleavage site and another one 0 to
6 amino acids before, are widespread among neuropeptides, hormones and growth factors of different
organisms. This motifs are cleaved by subtilisin-like proprotein convertases (calcium dependent serine
proteases) and the resulting C-terminally exposed basic amino acids are subsequently removed by
metallo-carboxypeptidases [177,179–181]. Dibasic motifs or motifs with an extended distance between
the two basic residues have also been found in precursors of peptides from sea anemones, scorpions,
snakes and amphibians. Few of these motifs also feature Glu-residues in the range of +4 or −4 amino
acids from the cleavage site, making it possible to be additionally classified as PQMs and iPQMs [177].
Unambiguous PQMs are rarely present in precursor sequences (e.g., P86399). Thus spider venom
peptide maturing seem to rather represent an exception compared to the maturing of venom peptides
of other animals [81].
Toxin precursors of other animals may also feature a construction different from the classic spider
venom peptide precursor. Scorpion toxin precursors, for example, may be free of propeptides, contain
propeptides N-terminally of the mature peptide [86,182], or contain propeptides C-terminally of
their mature toxin [183,184]. We are not aware of C-terminal propeptides in spider venom peptide
precursors. Gomesin, however, an AMP isolated from spider hemocytes, contains a C-terminal
propeptide separated by a dibasic motif from the mature chain [185].
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Production of toxins through complex toxin precursors, giving rise to multiple mature peptides,
is not a singularity of spiders, but has also been described for other organisms including the toad
Bombina maxima [186], the sea anemone Urticina grebelnyi [187], and some centipedes [188]. Complex
structures of AMPs of the immune system are, among others, known from the honey bee [189], and from
plants [190].
2.6.2. Cleavage for Heterodimerization of Spider Toxins
Today, we know only a few heterodimeric neurotoxin-like peptides from spider venom. CsTx-13
(U2-ctenitoxin-Cs1a, P83919) from the spider Cupiennius salei is an ICK-motif peptide with two
inter-chain disulphide bridges (Figure 5D) acting synergistically with its main monomeric neurotoxin
CsTx-1 (omega-ctenitoxin-Cs1a, P81694) and its main cytolytic peptide cupiennin 1a (M-ctenitoxin-Cs1a,
P83619) [59]. In CsTx-13, the two chains are of similar length. The only other well characterized
heterodimeric spider venom toxin, omega-agatoxin-1A (P15969) of the agelenid Agelenopsis aperta,
in contrary, possesses a very short chain consisting of only three amino acids connected with a
disulphide bridge to a longer chain (Figure 5C) [191]. A homologue of omega-agatoxin-1A has also
been found in the venom gland transcriptome of Cupiennius salei (CsTx-40, MH754614) [107,178]. All
these peptides undergo heterodimerization by proteolytic cleavage of a monomeric precursor. The
precursor comprises both mature chains separated by short spacers (RSETDR, RSEESER, and RNEEAER,
respectively). The evident similarity of the precursor structure to the precursors of binary and complex
precursors of AMPs suggests an analogue maturing mechanism by cleavage of the PQM and iPQM
followed by removal of the residual Arg at the C-terminal end of the chain 1 [177,178].
Besides protease mediated cleavage of the peptide precursors, spider venom toxins may undergo
additional posttranslational modification. Commonly observed modifications include removal
of C-terminal Arg-residues by a so far uncharacterized carboxypeptidase, and peptidylglycine
alpha-amidating monooxygenase mediated C-terminal amidation of peptides (Figure 5) [107].
In addition, pyroglutamate formation at N-terminal glutamine, formation of O-palmitoyl threonine,
and isomerization of an amino acid have been described [176,192,193].
2.7. Concluding Remarks on Venom Components and Their Toxic Action
Here, we reviewed spider venom components in groups (i.e., small molecular mass compounds,
AMPs, cysteine-rich peptides, and proteins). Some venom components known today cannot be assigned
to any of the above groups. Among them are short peptides with similarity to peptide-hormones of
the kinin family, such as tachykinin-like short cationic peptides from the ctenid Phoneutria nigriventer,
that provoke smooth muscle contractions in guinea pig ileum [194], or bradykinin-potentiating
peptides from Lycosa erythrognatha (mentioned as Scaptocosa raptoria) [195,196] and Latrodectus
tredecimguttatus [197]. Some of these peptides have been shown to relax rat duodenum, increase
capillary permeability, and to inhibit angiotensin converting enzyme [196].
Despite the here presented description of the toxic action of single venom components or groups
of venom components, the importance of synergistic effects for the overall toxicity of venom should
not be underestimated. Examples for reported synergistic actions are enhanced toxicity of neurotoxins
in presence of potassium ions [58] or synergistic actions between the heterodimeric neurotoxin CsTx-13
(U2-ctenitoxin-Cs1a, P83919, Cupiennius salei) and the main monomeric toxin of the same spider (CsTx-1,
omega-ctenitoxin-Cs1a, P81694) [59]. In addition, neurotoxins with different functions may interplay
to ensure efficient effects in the prey. For example, it can be assumed, that the δ-toxins, and the κ-toxin
co-occurring in the venom of the theraphosid Chilobrachys guangxiensis preserve action potentials
(delayed inactivation of NaV channels through δ-toxins) and simultaneously prevent their termination
(blocking activation of KV channels by κ-toxin) leading to tetanic paralysis [198]. Synergistic actions in
insecticidal activity have also been reported for AMPs and neurotoxins [52,73].
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Additionally, it has been shown, that neurotoxins have a stronger affinity for ion channels,
if the lipid membrane contains more anionic ceramide 1-phosphate, than zwitterionic sphingomyelin.
Sphingomyelin is hydrolyzed to ceramide 1-phosphate by sphingomyelinase D, an enzyme found in the
venom of sicariid spiders, what implies a synergistic effect between neurotoxins and sphingomyelinase
D [199,200]. Synergistic actions are also assumed for glutamate and acylpolyamines. Acylpolyamines
block ionotropic glutamate receptors by inserting into the activated channel. Venom glutamate activates
these channels upon venom injection and thus allows efficient blockade [81].
The here mentioned synergistic actions between venom components are only the tip of the iceberg
and the interplay between venom components has only been marginally studied today. This especially
concerns venom proteins that have only recently gained in focus [107]. Furthermore, it can be assumed
that venom components may also have different purposes, sites, and time-courses of action [198].
Some components are likely to induce pain and mainly have a defensive purpose (e.g., ATP, serotonin,
histamine), others ensure reversible, but immediate paralysis, or traverse the blood-brain barrier to act
directly on the CNS and induce irreversible flaccid paralysis 20 to 30 minutes after injection [198]. All in
all, the envenomation process seems to rely on a complex interplay of different venom components,
which cannot be fully understood by individual characterization of the components. In the words of
the Greek philosopher Aristotle, one may state that venom is more than the sum of its parts.
3. Analysis of Venom Components
Spider venom research started mid of the 20th century [201]. First studies were mainly performed
with venom as a whole and especially concerned the effect of spider venom on animals and humans
including the development of antivenin [202]. Venom was obtained by electrical milking, similar
to the method which is still widely used today [203]. The small quantities of gained venom were
for a long time a limiting factor for analysis of single venom components. Only after the advent of
modern chromatographic separation techniques (especially high-performance liquid chromatography,
HPLC), scientists were equipped with the appropriate tools for efficient isolation of toxins from small
quantities of venom [34]. In the following years, multiple single peptide compounds and SMMCs
were described or isolated from venoms. Multidimensional liquid chromatography was the method
of choice for isolation of peptides [50,204–206]. Peptide sequences were often analyzed by Edman
degradation and SMMCs were investigated by methods including mass spectrometry [206,207] and
thin layer chromatography [50].
More and more emphasis was put on the development of drugs and insecticides from
venom components [208,209]. Venom components with activity against a desired target started
to get identified by assay guided fractionation using screening assays relying on methods as
automated-patch-clamp electrophysiology, or fluorescent-resonance energy transfer [210]. Upcoming
DNA sequencing techniques and soft ionization techniques for mass spectrometry (i.e., matrix-assisted
laser desorption/ionization (MALDI), and electrospray ionization (ESI)) accelerated venom research
and offered insights into venoms, that were only available in very limited quantities.
Researches started to investigate sequences of single transcripts [211,212]. This was followed
by generations of whole venom gland cDNA libraries, first sequenced by Sanger sequencing [16–19],
later by Roche 454 sequencing [20,21], and Illumina sequencing [22,24]. Transcript sequences started
to get used for cloning, design of mutants and heterologous expression, or chemical toxin synthesis to
gain new structural and functional information (for a recent review see [210]).
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Also in the last decade, mass spectrometry gained in importance for protein analyses and
was increasingly used to study venom peptides and proteins. While analysis were first mainly
restricted to purified components, rapid advances in detection speed, sensitivity, and coupling of liquid
chromatography to mass spectrometers enabled automated studies of complex mixtures of peptides
and proteins. An increasing number of transcriptomic studies were also paired with proteomic studies
offering complementary data. Today, integration of proteomic, genomic and transcriptomic approaches
in venom studies are termed venomics [213].
Transcriptomics and mass-spectrometry based proteomic studies are common in spider venom
research and are further detailed in the following paragraphs. Genomic studies of spiders are rare,
with only four genomes published so far (as of 9 July 2019): Stegodyphus mimosarum, Acanthoscurria
geniculata [214], Nephila clavipes [215], and Parasteatoda tepidariorum [167,216]. Additionally, three
genomes are deposited on the NCBI genome repository without any linked publication: Dysdera
sylvatica, Latrodectus hesperus, and Loxosceles reclusa. For spiders, genome sequencing and analysis has
been reported to be very challenging due to the high amount of repetitive elements likely to be a result
of gene and whole genome duplications [216,217]. These repetitive elements enormously complicate
de-novo assembly of reads. In this respect, the inclusion of data from long-read sequencing methods (see
below) has been proposed to overcome fragmented genome assemblies [215,217]. More high-quality
genomic data could thereby dramatically increase our understanding of the evolution of spider
venom components.
3.1. Venom Gland Transcriptome Analysis
Analysis of the venom gland transcriptome offers insight into the composition of protein and
peptide venom components and is the method of choice to study venom components if the availability
of venom is poor. In the early phase of transcript analysis, cDNA sequences were sequenced in
targeted approaches. The probably first transcriptomic analysis of spider venom toxins, performed
by the group of the Russian researcher Eugene V. Grishin, investigated the coding sequence of
alpha-latrotoxin by targeted sequencing of the respective clone from a cDNA library. The clone
was identified by hybridization of a synthetic oligonucleotide based on the sequence of a tryptic
peptide of alpha-latrotoxin [212]. Later, multiple studies used rapid amplification of cDNA ends
(RACE) [218–220], requiring a specific oligonucleotide for amplification of the cDNA of interest (3’
RACE) or for reverse transcription of the transcript of interest (5’ RACE) [221]. These labor-intensive
targeted sequencing approaches were soon replaced by random screening of cDNA libraries, allowing
parallel analysis of numerous venom peptide and protein coding transcripts.
Sequencing techniques are under fast development and a variety of different techniques have
been used for analysis of spider venom gland transcriptomes. As of 2 September 2019, 44 spider venom
gland samples are listed in the biological source material database BioSample (search: “Araneae”
[Organism] AND (venom [All Fields] AND gland [All Fields]; entries manually reviewed). Thereof,
12 samples have linked entries in the expressed sequencing tag database (dbEST) arising from Sanger
sequencing, and 32 in the short read archive (SRA), a repository for next generation sequencing data.
Many of the here deposited data, however, are not linked to and analyzed in original research papers.
Table 2 gives an overview on published transcriptomic data from spider venom glands.
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Table 2. Overview on selected transcriptomic studies of spider venom glands.
Spider Species Sex/Number of Specimens/TimeSince Last Milking Sequencing Method Total EST/Contigs Isolation of Sequences Based on
Identified
Toxins/Transcripts Ref.
Parasteatoda tepidariorum */**
(Theridiidae)
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tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
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to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
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/adult/3 d since last meal, o
milking
Illumina HiSeq 4000
(2 × 100 bp)
2 replicates
NA, aligned to
genome assembly differential expression analysis
1318 upregulated
transcripts [23]
Phoneutria pertyi
(Ctenidae)
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Basic Local Alignment Search Tool
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Cupiennius salei *
(Trechaleidae)
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Tetragnatha versicolor
(Tetragnathidae)
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Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huw na) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Ag lena orientalis 
(Agelenidae) 
NA / NA / NA Sang r (2166 lones) 
37 co tigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
M crothele gigas * 
(Dipluridae) 
NA / 2 gla ds / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
16,799 contigs,
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 69 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxosceles intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Cith rischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Un -
ProtKB)
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam),
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs,
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glan s. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = h ur. 
  
24,351 contigs
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Grammostola ro ea  
(Theraphosidae) 
NA / 30 / N  Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycos  singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Orni hoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 cl nes) NA 
BLAST, pairing with 
proteomic data from N-
t rm 
sequencing (Edman) 
88 p ptide toxins [239] 
Loxosceles intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* ( ub 
Citharischius craw hayi) 
(Theraph sida ) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sang r 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
LAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena oriental s 
( gelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence da aba es) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluri ae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies includ  proteomic experim nts; ** Studi s i clude further ti su s b sides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrie e toxin sequences from the contig databas . Databases us d for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = tr nscriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clone ) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hai anus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 a . / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequenc ng (Edman) 
88 peptide toxins [239] 
Loxoscel s i termedi   
(Sicariidae) ♂/ 350  5 d  (2400 lo ) 
1843 ESTs, 
257 ontigs, 
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[ 40] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae)
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena)
(Theraphosidae) 
NA / 20 / 4  Sanger 
468 , 
2  ti , 
65 i l t  
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [ 2] 
Loxosceles laeta 
(Sicariid e) ♀ / 100 / 5   
300  , 
3 6 ti , 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena or entalis 
(Agel nid ) 
NA / NA / NA Sang  (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 cl nes) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve tox n equences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult,  = ays, h = hour. 
  
Reads remapped against
combined assembly,
TRINOTATE pip line
, 9177 dimorphic,
1404 non-dimorphic [35]
Pardosa pseudoan ul ta **
(Lycosida )
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Grammostola rose   
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 E Ts 
BL ST (nrNCBI, Uni-
ProtKB) 
223 toxin-like t an-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Ornithoct n s hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. /  Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxosceles in ermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones)
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons
BLAST (GenBank,
ArachnoServer) 
11 toxin-l ke, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithocto u  
huwena) 
(Theraphos dae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nr CBI, U i-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies inclu e further tissues besides venom glands. The row “Isolation of sequences ba ed on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/15 ad./NA
Toxins 2019, 11, x F  PEE  E IE  22 of 47 
 
ra os ola rosea  
(Theraphosidae) 
 / 30 /  S nger (1500 clones) 869 EST BL ST 48 eptides [237] 
Lycosa singoriensis  
(Lycosidae) 
 / 20 / 4 d Sang r 833 ESTs 
BL ST (nr BI, ni-
Prot ) 
223 toxin-like tran-
scripts 
[238] 
yriopagopus hainanus * 
(sub rnithoctonus hai-
nana)  
The aphosidae) 
 / 20 ad. /  Sanger (1049 cl ne )  
BL ST, p i ing ith 
proteo ic data fro  -
ter  
sequencing (Ed an) 
88 peptide toxins [239] 
Loxo celes inter edia  
(Sicariidae) / 350 / 5 d 
Sanger (2400 clones) 
1843 EST , 
257 contigs, 
281 singletons 
BL ST( enBank)
88 contigs, 80 single-
tons ( oxin sequences) 
[240] 
Pelinobius uticus* (sub 
itharischius cra shayi) 
(Theraphosidae) 
 / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BL ST ( enBank, 
rachn S rver) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
yriopagopus sch idti 
(sub rnithoctonus 
hu ena) 
The aphosidae) 
 / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
5 singletons 
BL ST (nr BI, ni-
Prot B) 
31 ture peptides [242] 
Loxosceles laeta 
(Sicariidae)  / 100 / 5 d 
Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BL ST, do ain predi -
tion (S T / Pfa ), 
signal peptide 
93 clusters of kno n 
toxins, 117 clusters of 
possible toxins 
[18]
gelena orientalis 
( gelenidae) 
 /  /  Sanger (2166 clones) 
37 contigs, 
332 singletons 
BL ST ( enBank, pep-
tide sequence databases) 
48 toxin-l ke structures [17] 
acrothele gigas * 
( iplurida ) 
 / 2 glands /  Sanger (300 clones)   10 ulti-cys peptides [16] 
* St ies i cl e roteo ic ex eri e ts; ** St ies i cl e f rt er tiss es esi es e o  la s. e ro  “Isolatio  of seq e ce  based o ” esc i e  t e et o s a lie  
to retrie e toxi  se e ces fro  t e co ti  ata ase. ata ases se  for S  are i e  i  rac ts. ata ot a aila le fro  t e cite  ref re ce is esi ate  as  ( ot 
a aila le). e follo i  a re iatio s are se : S  = tra scri to e s ot  asse l  r tei  ata ase.  = e e o tolo  a otatio ,  = o e  rea i  fra e 
re ictio , s = i  ar o  o els, a . = a lt,  = a s,  = o r. 
  
/15 ad./NA
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 8 peptides [237] 
Lycosa singoriensis 
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs
BLAST ( rNCBI, Uni-
Pro KB)
223 toxin-like ran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing wi h 
proteomic data from N-
term
sequencing (Edma ) 
88 peptide toxins [239] 
Loxosceles intermedia 
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 EST , 
257 co tigs,
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosida ) 
NA / 1 / d Sang r (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer)
11 toxin-like, 3 puta-
tive toxin tran cripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 con gs,
65 singleton  
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 single ons
BLAST, domain predi -
tion (SMART / Pfam), 
ignal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 si gletons 
BLAST (GenBank, pep-
tide seq ence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Diplurida ) 
NA / 2 glands / NA Sa g r (300 clon s) NA NA 10 multi-cys peptides [16] 
* Studies include proteom c experiments; ** Studies includ  fu ther tis ues besides venom gl nds. The row “Isolation of sequences base  on” describes the methods applied 
to retrieve t xin sequenc s from th  contig database. Databas s used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
vailable). The following abbreviations are used: TSA = transcri t me sho gun assembly protein datab se. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/45
ad./NA (tissue
expression profiling)
Illumina HiSeq 75,9 0 contigs
ST (nrNCBI, ntNCBI,
SwissP ot), domain prediction, GO,
cys pattern
48 potential
peptide toxins [224]
Phoneutria nigriventer *
(Ctenidae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 8 9 ESTs BLAST 48 peptide  [237] 
Lycosa singoriensis  
(Lycosi ) 
NA / 2  / 4  r 833 ESTs 
BLAST ( rNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyr op gopus hainanus * 
(sub Ornithoc nus hai-
nana) 
(Theraphosidae) 
♀ / 20 ad. / NA Sang r (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequenci g (Edman) 
88 peptide toxi [239] 
L xosc les intermedia  
(Sicar idae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(GenBa k) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraph sidae) 
NA / 1 / 2 d Sanger (282 clones) 
23  ESTs, 
14 conti s, 
30 single on
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger
468 ESTs, 
24 contigs, 
65 singletons 
BLAST ( rNCBI, Uni-
ProtKB) 
31 ature pe tides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Ag lenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/20 ad./48 h
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Grammost la rosea  
(Theraphosidae) 
  30 / NA r (1500 clones) 869 S s BLAST 48 peptides [237] 
Lyc sa singor en is  
(Ly osid e) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopago us ainanus * 
(sub Ornithoctonus hai-
na a)  
(Ther phosid e) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with
prote ic data from N-
term 
s que cing (Edman) 
88 peptide toxins [239] 
Loxosceles ntermedia  
(Sicari dae) ♀♂/ 350 / 5 d S nger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 single on
BLAST(GenBank) 
88 contigs, 80 singl -
ton  (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius c awshayi) 
(Theraphosi ) 
NA / 1 / 2 d Sanger (282 clones) 
2 6 ESTs, 
14 co tig , 
30 singl tons 
BLAST (GenBank, 
A achnoS rver) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriop g pus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 ingletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
10 1 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena or e talis 
(Agel nidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, p p-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/10 ad./48 h
Illumina (2 × 151 bp)
HiSeq 1500 Sanger
(1476 ele trograms)
49,992 contigs
1224 ESTs, 132 contigs,
162 si gletons
BLAST (U iPr tKB, TSA), domain
prediction, GO, expr sion level
BLAST (UniProtKB), ORF, signal
peptide, propeptide
99 or 98 cy -rich
peptide toxins [154]
Poecilotheria Formos *
(Theraphosida )
Viridasius fasciatus *
(Viridasiidae)
Latrodectus mactans *
(Theridiidae)
Heteropoda davidbowie *
(Sparassida )
NA/9 ad./
0, 2, , 4 d
NA 10 ad./
0, 2, 3, 4 d
/39 ad./
0, 2, 3, 4 d
NA/9 ad./
0, 3, 7 d
Ion Torrent
9 ,148
co tigs
0,060
cont gs
301,423
co ti s
239,749
contigs
priv te HMMs based on
ArachnoServ r s qu nces, read
count thresho d
37 toxins
41 toxins
10 toxins29 toxins
[225]
Cyriopagopus hainanus (sub
Haplopelma hainana)
(Theraphosid e)
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Grammostola rosea  
(Theraphosidae) 
 / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [23 ] 
Lycosa singorie sis  
(Lyc sidae) 
NA / 20 / 4 d San er 833 ESTs 
BLAST (nrNCBI, Uni-
ProtK ) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub O nit ctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic d ta from N-
t rm 
sequencing (E man) 
88 peptide toxins [239]
Loxosceles intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
843 ESTs, 
57 contigs, 
281 singletons 
BLAST(GenB nk) 
88 contigs, 80 singl -
tons (toxin seq ences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/1 ad./NA
Illumina (2 × 101 bp)
HiS q 2000 57,181 contigs
BLAST (Toxprot, UniProtKB), ys
cou t ≥ 5, domain predi ion 201 potenti l toxins [226]
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Table 2. Cont.
Spider Species Sex/Number of Specimens/TimeSince Last Milking Sequencing Method Total EST/Contigs Isolation of Sequences Based on
Identified
Toxins/Transcripts Ref.
Lycosa vittata
(Lycosidae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxosceles intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/6 ad./NA Sanger (500 clones) NA NA 51 t i -like peptides [227]
Cyriopagopus hainanus (sub
Haplopelma hainana)
(Theraphosidae)
NA/NA/2 d 454 GS-FLX 65,432contigs
BLAST (EST NCBI, nrNCBI), ORF,
cys count ≥ 4, length ≥ 45
amino acids
1136
potential precursors [228]
Dolomedes sulfureus (Pisauridae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosi e) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[ 38] 
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 cl es) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [ 39] 
Loxosceles intermedia  
(Sicariid e) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 s, 
257 c ti s, 
281 si let s 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[ 0] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sang r 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
ti n (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/10 ad. 4 d Sanger (500 clones)
267 ESTs,
25 contigs,
58 singletons
BLAST (nrNCBI, UniProtKB)
127 putative toxin
precursors,
90 mature peptides
[229]
Plectreurys tristis * (Plectreuridae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1 49 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxoscele intermedia  
(Sicariidae) ♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(G nBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoc onus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 i l t  
BLAST (nrNCBI, Uni-
ProtKB) 
31 matu e pep ides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d S nger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/5/3, 4 d anger (1717 clones)
307 ESTs,
37 contigs,
105 singleto
BLAST (ArachnoServer, NCBI,
private dbs)
19 putative
peptid transcripts [230]
Cyriopagopus schmidti (sub
Ornithoctonus huwena)
(Theraphosidae)
NA/3/2 d 454 GS FLX Titanium 4224 conti s
BLAST (UniProtKB, ToxRelDB,
Repbase),
cys att rn
626 toxin precursors,
90 mature peptides [231]
Latrodectus Hesperus */**
(Theridiidae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagop s hainan s * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxo celes intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 s, 
14 c ti s, 
0 si l t s 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
L xosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/7/NA Illumina (2 × 100 bp) 85,193 contigs
ST (UniProtKB), ORF
prediction, differ ntial express on
analysis
695 v nom gland
specific transcripts
[22]
[232]
Dolomedes fimbriat s
(Pisauridae) NA/several 7 Sange (5952 clones) 451 contigs
cys pattern search, signal
peptide, propeptide
451 transcripts, 163
mature peptides [233]
Selenotypus plum pes
(Theraphosidae) NA/2/NA 454 GS-FLX
136,469 six-frame
translated
sequences
ORF prediction, BLAST
(ArachnoServer) sig al peptide,
propeptide, cys count
970 mature (likely to
be an overestimate) [234]
Trittame lok i *
(Barychelidae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxosceles intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 singletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/9/4 d 454 GS FLX Tita ium 4711 contigs BLAST UniProtKB
46 full-length toxin
pr cursors [21]
Dolomedes mizhoanus
(Pisauridae)
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Gramm stol  rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singorien is  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
8  
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA S ge  (1049 clones) NA 
BLAST, pairing with
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxosceles intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 c nt gs, 
281 singletons 
BLAST(Ge Bank) 
88 c ntigs, 80 single
tons (toxin sequence ) 
0  
Pelinobius m ticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Un -
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sicariidae) ♀ / 100 / 5 d Sanger 
008 EST , 
6 contigs, 
1031 singletons 
, domain predic
tion (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA S nger (300 clones) NA NA 10 multi-cys peptides [16]
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/1/4 d Sanger
356 ESTs,
19 contigs,
26 singletons
BLAST (nrNCBI, UniProtKB)
signal peptide, SpiderP
53 or 55 cys-knot
toxin pr cu sors, 48
mature peptides
[235]
Latrodectus tredecimguttatus
(Theridiidae) NA/3 ad./NA
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sa ger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxi -like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
( ub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxoscele  intermedia  
(Sic riidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
1843 ESTs, 
257 contigs, 
281 ingletons 
BLAST(GenBank) 
88 contigs, 80 single-
tons (toxin sequences) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
Arachn Server) 
11 t xin-like, 3 puta-
tive toxin transc ipts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 si gletons 
BLAST (nrNCBI, Uni-
ProtKB) 
31 mature peptides [242] 
Loxosceles laeta 
(Sic riidae) ♀ / 100 / 5  Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
ti n (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clust rs f 
po sible toxins 
[18] 
Agelena orientalis 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys peptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
15/4
Illumina (2 × 90 bp)
HiSeq 2000 Sanger
34,334 contigs
1015 unique ESTs
ORF prediction, BLAST
(UniProtKB), Cys-pattern, domain
prediction (SMART/Pfam)
146 toxin-like proteins [24]
Araneus ventricosus *
(Araneidae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
NA / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus ainanus * 
( b Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 cl es)  
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxosceles intermedia  
(Sicariid ) ♀♂/ 35  / 5  Sanger (2400 clones) 
1843 s, 
257 c ti s, 
281 si let s 
BLAST(GenBank) 
88 contigs, 80 singl -
t ns (toxin seque ces) 
[240] 
Pelinobius muticus* (sub 
Citharischius crawshayi) 
(Theraphosidae) 
NA / 1 / 2 d Sanger (282 clones) 
236 ESTs, 
14 contigs, 
30 singletons 
BLAST (GenBank, 
ArachnoServer) 
11 toxin-like, 3 puta-
tive toxin transcripts 
[241] 
Cyriopagopus schmidti 
(sub Ornithoctonus 
huwena) 
(Theraphosidae) 
NA / 20 / 4 d Sanger 
468 ESTs, 
24 contigs, 
65 singletons 
BLAST (nrNCBI, Uni-
Pr tKB) 
31 mature peptides [242] 
Loxosceles laeta 
(S cariidae) ♀ / 100 / 5 d Sanger 
3008 ESTs, 
326 contigs, 
1031 singletons 
BLAST, domain predic-
ti n (SMART / Pfam), 
signal peptide 
93 clusters of known 
toxins, 117 clusters of 
possible toxins 
[18] 
Agelena orienta is 
(Agelenidae) 
NA / NA / NA Sanger (2166 clones) 
37 contigs, 
332 singletons 
BLAST (GenBank, pep-
tide sequence databases) 
48 toxin-like structures [17] 
Macrothele gigas * 
(Dipluridae) 
NA / 2 glands / NA Sanger (300 clones) NA NA 10 multi-cys p ptides [16] 
* Studies include proteomic experiments; ** Studies include further tissues besides venom glands. The row “Isolation of sequences based on” describes the methods applied 
to retrieve toxin sequences from the contig database. Databases used for BLAST are given in brackets. Data not available from the cited reference is designated as NA (not 
available). The following abbreviations are used: TSA = transcriptome shotgun assembly protein database. GO = gene ontology annotation, ORF = open reading frame 
prediction, HMMs = Hidden Markov Models, ad. = adult, d = days, h = hour. 
  
/20/3 Sanger 886 ESTs ≥4 cys, signal pept de 200 toxin-likerecursors [236]
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Table 2. Cont.
Spider Species Sex/Number of Specimens/TimeSince Last Milking Sequencing Method Total EST/Contigs Isolation of Sequences Based on
Identified
Toxins/Transcripts Ref.
Grammostola rosea
(Theraphosidae) NA/30/NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237]
Lycosa singoriensis
(Lycosidae) NA/20/4 d Sanger 833 ESTs BLAST (nrNCBI, UniProtKB)
223 toxin-like
transcripts [238]
Cyriopagopus hainanus * (sub
Ornithoctonus hainana)
(Theraphosidae)
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Grammostola rosea  
(Theraphosidae) 
NA / 30 / NA Sanger (1500 clones) 869 ESTs BLAST 48 peptides [237] 
Lycosa singoriensis  
(Lycosidae) 
 / 20 / 4 d Sanger 833 ESTs 
BLAST (nrNCBI, Uni-
ProtKB) 
223 toxin-like tran-
scripts 
[238] 
Cyriopagopus hainanus * 
(sub Ornithoctonus hai-
nana)  
(Theraphosidae) 
♀ / 20 ad. / NA Sanger (1049 clones) NA 
BLAST, pairing with 
proteomic data from N-
term 
sequencing (Edman) 
88 peptide toxins [239] 
Loxosceles intermedia  
(Sicariidae) ♀♂/ 350 / 5 d Sanger (2400 clones) 
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First venom gland transcriptomes were analyzed by Sanger sequencing [16,17]. mRNA was
isolated, reverse transcribed, cloned into plasmids, amplified in bacteria, and finally the inserts
of plasmids were sequenced by Sanger sequencing. This method generates sequences of up to
900 nucleotides in length, referred to as expressed sequencing tags (ESTs) [243]. Depending on the
length of a transcript, ESTs may not span an entire transcript, but only represent portions of it. An
attempt to decrease the data complexity for downstream analysis is to assemble ESTs belonging to the
same mRNA to so called contigs. This computational process, however, is not trivial and may produce
artefact contigs that do not represent real mRNAs. The availability of reference sequences, such as a
reference genome, can therefore significantly improve transcriptomic analysis as ESTs do not need to be
de-novo assembled, but can simply be mapped to reference sequences. High-quality spider genomes,
however, are extremely rare and sequencing reads are usually de-novo assembled. De-novo assembly
quality is significantly influenced by the length of the assembled sequencing reads with longer reads,
resulting in better assemblies [210]. Development of next generation sequencing techniques, such
as 454 sequencing or Illumina sequencing drastically increased the number of generated sequencing
reads, allowing to generate more comprehensive transcriptomic data and to better estimate transcript
abundance from the number of respective reads. However, these advances came at the cost of worse
accuracy and shorter sequencing reads (e.g., depending on the protocol, mostly 150 base pairs (bp)
for Illumina or up to 700 bp for 454 sequencing [243]) complicating de-novo assembly, especially
for Illumina data. While Sanger sequencing of venom gland transcriptomes often resulted in the
generation of approx. 100 contigs and somewhat more ESTs, that could not be assembled (referred
to as singletons), reads from next generation techniques are often assembled to several thousands of
contigs (Table 2), requiring bioinformatic tools to identify sequences of toxin-like peptides from the
database of contigs.
3.1.1. Identification of Toxin-Like Transcripts
Different strategies have been used to identify toxin-like peptides from transcriptomic data
(Table 2). The most widely used approach is Basic Local Alignment Search Tool (BLAST) of contigs
against specialized databases containing known toxins, such as ArachnoServer [46,47], the animal
toxin database of UniProt (ToxProt), or more comprehensive databases, such as UniProtKB. Many
studies also incorporate protein domain prediction and gene ontology annotation of contigs. Hits are
typically searched for toxin related terms and are manually reviewed. While many studies focus on
neurotoxin-like peptides, structural features of the latter are also commonly used for toxin identification.
These include cysteine count, cysteine pattern search, and presence of signal and/or propeptide cleavage
sites. Prediction of possible propeptide cleavage sites was significantly improved with the publication
of spiderP and its successor spiderProHMM, both automated propeptide prediction software for
spider toxins. Many of the above-mentioned approaches assume a certain degree of similarity of
newly identified toxin-like peptides with known toxins. This makes it challenging to identify entirely
new toxin families. In addition, as toxins are derived from body peptides, simple homology search
approaches (e.g., BLAST) involve the danger of identifying body peptides and wrongly annotating them
as toxins (i.e., wrong positive) [244]. The number of false positive identifications may be diminished
by integration of proteomic data, phylogenetic analysis of putative toxin families, and/or the use of
comparative transcriptomics of non-venom producing tissues and venom gland [244,245]. Accordingly,
Haney et al. [22] used a multi-tissue sequencing approach to investigate the venom of the spider
Latrodectus hesperus and sequenced mRNA isolated from venom gland, silk gland, and the prosoma
without the venom gland, allowing to identify transcripts with venom gland biased expression.
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Comparison of transcriptome derived toxin-like sequences with transcriptomic data of haemocytes
was recently used to reinforce venom gland specific expression of single toxins of Cupiennius salei
Kuhn-Nentwig et al. [107], and Huang et al. [224] compared tissue specific expression of toxin-like
peptides and proteins identified in the venom gland transcriptome of the lycosid Pardosa pseudoannulata.
Putative cysteine-rich venom peptides were found to be uniquely or predominantly expressed in
the venom glands while some putative venom protein coding transcripts showed surprisingly high
expression levels in brain tissue or fat body. This demonstrates the complexity to accurately predict
venom proteins from transcriptomic data.
The identification of toxin-like sequences may be influenced by the protocol of data analysis.
Different protocols for data acquisition, however, may also influence toxin recovery and quantification.
For example, transcript levels may be influenced by the duration between the last venom gland
depletion by milking or feeding, and the dissection of venom glands. Many studies report a timeframe
between 48 h and one week from last milking to dissection of the venom glands (Table 2). Venom
gland dissection is even performed at different time intervals after milking in some studies to diminish
the potential effects of a time-dependent expression of certain venom components. Experimental data
on time-dependent expression of venom peptides and proteins, however, is lacking.
Toxin discovery may also substantially depend on the used sequencing method. Comparing
454 with Illumina sequencing, the greater read depth of Illumina has been shown to improve toxin
discovery. In a recent studies of the venom of the remipede crustacean Xibalbanus tulumensis, 23 of 32
toxin families were only identified from Illumina data [246], and for Conus tribelei, 10 of 30 conopeptide
superfamilies were only identified from Illumina data [247]. Interestingly however, for the spider
Phoneutria nigriventer, Diniz et al. [154] identified more toxin-like peptides with traditional Sanger
sequencing than with Illumina sequencing.
3.1.2. Recent Developments in Sequencing Techniques
DNA sequencing techniques are currently under constant development. Meanwhile techniques
for single molecule sequencing, such as Oxford Nanopore Technologies (Nanopore), and Pacific
Bioscience (PacBio), termed third generation sequencing, are increasingly available. To our knowledge,
these techniques have so far not yet been applied for spider venom gland studies. With read lengths
between 10,000 and 100,000 bases, third generation sequencing techniques produce much longer reads
than next generation sequencing [248]. These read lengths enable full-length mRNA sequencing
overcoming problems in de-novo assembly often encountered in next generation sequencing protocols.
Full-length mRNA sequencing also provides a significant advantage for quantification of transcripts of
closely related isoforms [249]. This can be challenging with short read methods as a read may not be
unambiguously assigned to a single isoform.
Third generation sequencing methods, however, have two major drawbacks. (1) High error rates
of up to 15% (compared to approx. 0.1% for Illumina), and (2) low throughput compared to Illumina
sequencing [249]. These drawbacks can be diminished if data from third generation sequencing is
jointly assembled with data from a next generation sequencing technique [250,251]. This hybrid
assembly approach, has been shown to facilitate de-novo genome assembly, and may also be applicable
to study genomic data of spiders, which has up to now been a challenging task due to many repetitive
elements, difficult to assemble from short reads. Third generation sequencing techniques may also
drastically facilitate analysis of highly repetitive transcripts, such as the ones coding for complex
cytolytic precursors (see above). The attractiveness of using PacBio alone for de-novo genome or
transcriptome sequencing was very recently enhanced with the publication of a circular consensus
sequencing protocol allowing reduction of error rates to <1% for single-molecule reads of up to 15 kb
length [252,253].
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In spider venomic studies, third generation techniques have not established yet and many recently
published data were still acquired with next generation techniques or conventional Sanger sequencing.
While 454 sequencing was meanwhile discontinued by Roche, Illumina sequencing stays widely used
and gets further developed with the only recently released NovaSeq 6000 sequencing system.
3.1.3. Cross Contamination among Multiplexed Samples in Illumina Sequencing
Illumina is a sequencing by synthesis method relying on detection of fluorescent tagged nucleotides.
Synthesis is performed from templates immobilized on the surface of a so-called flow cell. One flow
cell thereby features several lanes (e.g., eight for Illumina HiSeq4000), in which the sequencing reaction
is performed physically separated. One lane generates up to 280 million reads of 125 bp if sequenced
with the meanwhile discontinued Illumina HiSeq2500. The number of reads per lane is even higher
in newer Illumina sequencing solutions, such as Illumina HiSeq4000, and Nova Seq 6000, that use a
special flow cell surface (patterned flow cells).
This high number of reads is an overkill for many analyses, however, economical use of sequencing
capacities is possible using multiplexing, the sequencing of multiple different samples in one sequencing
lane. For sample multiplexing, adapters with sample-specific indexes (barcodes) are attached to each
sequencing fragment during the preparation of the sequencing library. Subsequently, multiple libraries
can be pooled and sequenced in the same sequencing lane. The unique indexes are sequenced in a
separate sequencing run and are used to reassign a sequence read to its respective sample in a process
called demultiplexing. Despite the wide use of multiplexing, recent studies unveiled massive cross
contamination between multiplexed samples caused by misassignment of individual reads to the
wrong sample. This “index hopping” or “index swapping” was early described by Kircher et al. [254]
who proposed the use of double barcoding (e.g., the use of two separate indexes per sample, introduced
in the 3’ and 5’ adapter) to diminish the problem.
It took some years until Illumina itself and further scientists published studies concerning index
misassignment. Today, Illumina states that the main underlying process is contamination from free
adapters that were not completely removed during library preparation [255]. These adapters can lead
to extension of library fragments with the wrong index adapter, an effect which is bigger if cluster
generation is achieved via ExAmp chemistry used for patterned flow cells, as used for HiSeqX, HiSeq
4000/3000, and NovaSeq 6000. Illumina itself estimates the misassignment rates up to 2% and ≤1%
for patterned and non-patterned flow cells, respectively [255]. Using patterned flow cells and single
indexing, Costello et al. [256] reported 0.2% to 6% (average 0.89%) cross contamination by index
misassignment, that can however be significantly reduced using non-redundant double-indexing and
filtering of unexpected adapter combinations during demultiplexing. Even higher contaminations
of 5% to 7% were reported by Sinha et al. [257]. Studies showed, that non-patterned flow cells
performed way better with contaminations of 0.09% to 0.6% in MiSeq [256] or even complete absence of
misassignment [257]. Interestingly, Griffiths et al. [258] reported up to 2.5% misindexing, however found
free DNA barcode concentrations not to affect the rate of cross contamination. Owens et al. [259] could
not find index swapping in data neither from HiSeq 2500 nor from HiSeq X. In summary, studies show
different cross contamination rates of 0–10% but commonly propose to diminish cross contamination
by use of non-redundant double barcoding and/or completely abandoning multiplexing [257,259].
The reported rates of cross contamination may be a big issue in experiments concluding results
from very low expressed genes, such as some recent experiments in cancer genomics [256]. Non-realized
cross contamination between multiplexed samples may also have a significant impact on the outcome
in venomic studies. For example, multiplexing of venom gland transcriptome libraries of different
organisms may lead to the wrong conclusion that these organisms share common venom peptides
or proteins. Expression level estimates will surprisingly show that the related transcripts are low
expressed in all but one organism. While the experienced scientist may recognize that the results
as biased, especially if the phylogenetic distance between the multiplexed organisms is high, cross
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contamination in multiple tissue profiling experiments may be a bigger issue. Venom gland specific
transcripts may be found at lower expression levels in other tissues as well.
Interestingly, a similar case has been recently described in a study comparing the transcriptomes
of venom glands, silk glands, ovaries, and the prosoma without the venom glands of Parasteatoda
tepidariorum ([23] STable6). The authors reported that “in contrast with the selective expression in
the venom gland as posited in the traditional model of venom evolution . . . , many of the individual
transcripts that produce venom proteins in this study have some level of expression in other tissues
(silk, ovary, or cephalothorax).” [23]. The exact sequencing conditions including multiplexing level and
samples multiplexed are not disclosed. Upon request, the corresponding author stated that sequencing
was done in a single lane of an Illumina HiSeq4000 instrument. Some libraries were re-sequenced in
a different sequencing run under non-disclosed multiplexing conditions (personal communication,
Haney 2019). In the light of the latest findings concerning cross-contamination in Illumina sequencing,
it cannot be excluded that some these transcripts may rather be a result of cross-contamination than
they are truly expressed in other tissues.
3.2. High Throughput Mass Spectrometric Analysis of the Venom Proteoms
For a long time, the method of choice for sequence analysis of venom peptides and proteins
was purification of analytes and subsequent Edman degradation. This labor- and cost-intensive
approach lost in importance with upcoming high-throughput mass spectrometric techniques [34].
Today, two main workflows are used in mass-spectrometry based comprehensive analyses of proteomes:
(1) Tandem mass spectrometric analysis of fragments resulting from enzymatic or chemical digestion
of proteins and peptides (bottom-up proteomics), and (2) direct analysis of intact proteins and peptides
by tandem mass spectrometry (top-down proteomics).
3.2.1. Bottom-Up Proteomics
Most proteomic studies of venoms use bottom-up approaches. Some studies involve extensive
decomplexation of samples down to single peptides/proteins or groups of peptides/proteins prior
to proteolytic digestion. A standard protocol developed for the analysis of snake venom starts
with decomplexation of venom by fractionation through reverse phase HPLC (RP-HPLC). RP-HPLC
fractions are subsequently separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE), single protein bands are excised from the gel, and proteins are in-gel digested with a
protease (mostly trypsin). The generated protein fragments are analyzed by tandem mass spectrometry
to gain sequence information. Relative abundances of venom peptides and proteins can be estimated
from the peak integral of PR-HPLC peaks and/or the staining intensity of bands in SDS-PAGE. Another
approach for oﬄine-separation and relative quantification of venom components is 2D electrophoresis
(isoelectric focusing and SDS-PAGE) of venom. This 2D gel-based approach, however, bears some
constraints in quantification of very low or very highly expressed peptides and proteins due to the
limited dynamic range of protein concentration that can be resolved by electrophoresis [260].
Extensive decomplexation of samples before proteolytic digest allows to gain further information
of single peptides/proteins or groups of peptides/proteins. For example, gels may be blotted
to a membrane for subsequent immunoblotting analysis using antivenoms [261,262]. However,
decomplexation of venom components and handling of dozens of single samples for downstream
mass spectrometric analysis is cost- and labor-intensive. Direct mass-spectrometric analysis of peptide
and protein fragments resulting from proteolytic digestion of crude venom, or venom fractionated
in only few fractions is significantly faster and easier to perform. In this approach, also termed
“shotgun” proteomics, fragments resulting from proteolytic digestion of peptides and proteins are
typically separated by capillary RP-HPLC and sequenced by on-line tandem mass spectrometry.
Multidimensional separation of peptide and protein fragments (e.g., by ion-exchange chromatography
and RP-HPLC) can thereby increase peptide resolution. Direct shotgun proteomics is highly sensitive
and also reveals information on small peptides (<2–3 kDa), which may be lost in gel-based approaches.
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The major drawback, however, is the lack of easy possibilities for quantification of venom components.
Isotope based methods for absolute quantification require sample spiking with one specific isotope
labelled standard per quantified proteoform, which is not applicable [263]. Label-free quantification
techniques based on fragment ion peak intensities may be used for the relative comparison of identical
components among different samples (comparative proteomics), but are not suitable for quantification
of different components in one sample [260]. Thus, shotgun-proteomics may be suitable to provide
qualitative, but not quantitative information on venom components [230].
In all of the above-mentioned methods, proteolytically digested proteins and peptides are
fragmented in a mass spectrometer (usually by collision induced decay, CID) to gain sequence
information from fragment spectra. The several thousands of resulting fragment spectra are in-silico
matched against a database of possible proteins. In the best case, this database consists of protein
sequences deduced from transcriptomic or genomic data of the analyzed species. Lack of this data often
limits the identification of single proteins and mostly only allows to assign proteins to a known protein
family based on similarity of short sequence stretches. Protein families are thereby either identified
by direct search of fragment ion spectra against a more comprehensive database (e.g., containing all
spider proteins) or, allowing also identification of less similar proteins, by de-novo sequencing and
subsequent search of de-novo sequenced fragments against a comprehensive database.
The majority of recently published proteomic studies on spider venom are not quantitative and
use shotgun approaches and species-specific databases for matching of fragment ion spectra (for an
overview on selected studies see Table 3). Sequence databases are mostly derived from translated
sequences of a transcriptome analysis performed in the same study and proteomic results are used for
qualitative validation of peptides inferred from transcriptomic data. For identification of proteins and
protein families, few studies used non-species-specific databases or de-novo sequencing. De-novo
sequencing was used in combination with database searches by Duan et al. [236] and Liao et al. [264].
In the analyzed studies, components of crude venom were either directly digested or pre-separated
(mostly by SDS-PAGE) prior to digestion and mass spectrometric analysis. Multiple studies combined
different protocols for maximizing data output. Gel-based and direct crude venom analysis were used
by Santana et al. [265], and Duan et al. [236]. Other studies used enzymes with different specificities to
improve the protein coverage [107,266].
Incomplete protein coverage and ambiguity in assigning sequenced fragments to closely
related protein isoforms is a major difficulty in bottom-up proteomics, especially in shotgun
approaches. This not only affects proteoform identification but also MS-based quantification [1,267,268].
Differentiation of isoforms is only possible if a unique peptide for each isoform can be unambiguously
sequenced. Incomplete sequence information also significantly complicates the identification of
heterodimeric toxins, e.g., CsTx-13 (U2-ctenitoxin-Cs1a, P83919) or omega-agatoxin-1A (P15969), or
of C-terminally truncated toxins, e.g., CsTx-2a or CsTx-2b (omega-ctenitoxin-Cs1a, P81694)). These
shortcomings may be eliminated by the use of top-down proteomics.
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Table 3. Overview on selected high-throughput mass spectrometric studies of spider venom.
Spider Species Top-Down Bottom-Up VenomPre-Fractionation Digest Post-Fractionation
Data Analysis
Type Database Identified Toxins Reference
Parasteatoda tepidariorum *
(Theridiidae) X
SDS-PAGE
(8 fractions) in-gel trypsin online RP-HPLC db-dependend
predicted transcripts from
genome assembly ≥99 distinct proteins [23]
Cupiennius salei *
(Trechaleidae)
X SEC, desalting trypsin,chymotrypsin online RP-HPLC db-dependend UniProtKB Araneae sequences +
identified transcripts
49 peptides,
≥23 proteins [107]
X SEC, desalting,online RP-HPLC - - db-dependend
Tetragnatha versicolor *
(Tetragnathidae) X
SDS-PAGE
(3 fractions) in-gel trypsin
NA, (probably
online RP-HPLC) db-dependend
translated transcriptome
sequences + NCBI chelicerate
sequences
62 distinct proteins in 31 clusters [35]
Phoneutria nigriventer *
(Ctenidae) X - trypsin MudPIT db-dependend
predicted proteins from
transcriptome 29 cys-rich peptide toxins [154]
Selenocosmia crassipes
(sub Phlogius crassipes)
(Theraphosidae)
X - trypsin online RP-HPLC db-dependend UniProtKB Arthropoda
sequences
Ontogenetic analysis, depending
on group: 12, 11, 8, or 8 [265]X SDS-PAGE in-gel trypsin online RP-HPLC
Pamphobeteus verdolaga *
(Theraphosidae) X RP-HPLC Lys-C/trypsin online RP-HPLC db-dependend
some with sequences from
UniProt, NCBI or the
ArachnoServer
16 peptides [269]
Loxosceles intermedia
(Sicariidae) X
10 kDa cutoff
spin-column
trypsin,
pepsin,
chymotrypsin
online RP-HPLC/
MudPIT
de-novo,
spectral-network
algorithmes
de-novo sequences against
Loxosceles UniProt sequences + L.
intermedia vg transcriptome
190 proteins [266]
Poecilotheria Formosa *
(Theraphosidae)
Viridasius fasciatus *
(Viridasiidae)
Latrodectus mactans *
(Theridiidae)
Heteropoda davidbowie *
(Sparassidae)
X solid phaseextraction NA online RP-HPLC db-dependend
assembled contigs from
transcriptome sequencing
103
9
4
68
[225]
Plectreurys tristis *
(Plectreuridae) X SDS-PAGE in-gel trypsin - db-dependend
plectreurid transcriptome,
private haplogyne vg cDNA
libraries, chelicerate seq. in NCBI
7 astacins-like groups,
7 peptide groups,
1 unknown
[230]
Latrodectus Hesperus *
(Theridiidae) X NA trypsin MudPIT db-dependend
Latrodectus hesperus seq. on
NCBI, ESTs (vg specific) +
assembled transcriptome
61 [22]
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Table 3. Cont.
Spider Species Top-Down Bottom-Up VenomPre-Fractionation Digest Post-Fractionation
Data Analysis
Type Database Identified Toxins Reference
Trittame loki *
(Barychelidae)
X NA trypsin online RP-HPLC db-dependend translated cDNA library 45 [21]
X online RP-HPLC - -
Araneus ventricosus *
(Araneidae)
X
2D gel
electrophoresis
(106 spots)
in-gel trypsin online RP-HPLC db-dependend,
de-novo
NCBInr with animal species
restriction, de-novo sequences
matched against transcriptome
db-dependend (functional
analysis): 65 de-novo: 130 [236]
X - trypsin online RP-HPLC
Latrodectus tredecimguttatus
(Theridiidae)
X SDS-PAGE in-gel trypsin online RP-HPLC db-dependend,
de-novo
NCBInr with animal
species restriction
75 venom proteins [270]
X - trypsin online RP-HPLC
Chilobrachys guangxiensis (sub
Chilobrachys jingzhao)
(Theraphosidae)
X
SEC, > 10 kDa:
2D gel
electrophoreses,
in-gel trypsin online RP-HPLC, - db-dependendmanually de-novo
raw genome data of the
arthropod; de-novo:
MS-BLAST
47 from in-gel digestion [264]
Data not available from the cited reference is designated as NA (not available). To following abbreviations are used: SDS-PAGE = sodium dodecyl sulphate polyacrylamide gel
electrophoresis, RP-HPLC = reverse phase high performance liquid chromatography, SEC = size exclusion chromatography, db = database, MudPIT = multi-dimensional protein
identification technology, vg = venom gland. * Studies include transcriptomics experiments.
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3.2.2. Top-Down Proteomics
In top-down proteomics, intact peptides and proteins are directly analyzed by fragmentation in the
mass spectrometer without prior digestion. The analysis of intact peptides and proteins, significantly
simplifies the identification of individual proteoforms with single nucleotide polymorphisms (SNP),
alternative splicing variants, and post translational modifications [267,271]. A prerequisite for top-down
analyses is the availability of a mass spectrometer with fast acquisition and high resolving power for
precursor and especially fragment ion spectra. Commonly used are Fourier-transform ion cyclotron
resonance and Fourier-transform orbitrap mass spectrometers [267]. Analytes are usually pre-separated
by online RP-HPLC. However, this cannot completely isolate all proteoforms. A higher degree of
pre-separation (e.g., by multidimensional HPLC) can increase the resolution and isolation of single
proteoforms resulting in more protein identifications [271]. Classic CID and HCD (higher-energy
collisional dissociation) may be used as fragmentation method, however electron-transfer dissociation
(ETD) or combined fragmentation approaches such as electron-transfer/higher-energy collision
dissociation (EThcD) are more popular, since they provide better protein coverage [267].
Top-down proteomics yields extremely complex spectra. Data analysis is performed in-silico and
includes isotopic peak picking and deconvolution followed by matching of fragment spectra against
a user-provided database of intact proteins, and statistical validation of protein identifications [271].
Top-down proteomics is especially suitable for analysis of peptides and small proteins up to approx.
30 kDa in mass [267] and analysis of high mass proteins is difficult [271]. Today, most venomic
studies still mainly relay on bottom-up proteomics. Top-down approaches are increasingly used to
complement bottom-up data of spider [21,107] and snake [272–276] venoms.
Recently, Calderon-Celis et al. [277,278] showed that snake venom proteins can be absolutely
quantified using a top-down proteomic approach. In their study, sulphur containing venom proteins
were in parallel (1) quantified via inductive coupled plasma (ICP) mass spectrometry using 32S/34S
isotope dilution and (2) identified by ESI QTOF-MS [277]. ICP-MS is a highly sensitive method normally
used in inorganic elementary analysis. Single atoms are ionized in a plasma and subsequently analysed
in the mass spectrometer. The generated ion-signal is thereby proportional to the ion concentration in
a wide dynamic range allowing absolute quantification of the ion concentration if a sample is spiked
with an isotopically enriched standard (isotope dilution) [263]. ICP-MS based quantification of venom
proteins may provide a promising tool for further venomic studies, but it also reveals a major challenge
ahead because the full separation of proteoforms prior to mass spectrometry is a prerequisite for
ICP-MS based quantification [277].
3.3. Annotation of Spider Venom Toxins
In the last decade, advances in omics techniques lead to a rapid increase in toxin sequences
deposited in online repositories. The main repositories for manually annotated and reviewed spider
toxin sequences are ArachnoServer [47] and ToxProt, the animal toxin annotation project of UniProt [279].
Sequences from high-throughput transcriptomics are often deposited in nucleotide sequence databases.
Many venomic studies today group newly identified toxins into families of similar toxins. Family
annotation is thereby conducted among toxins of a species and/or toxins are compared with entries of
inter-species repositories and annotated according to their similarity to known homologues. Detection
of homologue sequences is in many studies achieved by pairwise sequence comparison tools, such as
the Basic Local Alignment Search Tool (BLAST). An alternative approach is the use of profile Hidden
Markov Models (HMMs) for annotation of toxins to an existing protein or peptide family [107].
Such profile HMMs are statistical models often calculated from multiple sequence alignments
of protein domains, families, or structural motifs. For every position of a sequence, HMMs contain
probability scores for all possible amino acids, insertions, and deletions to occur at this given position.
Thus, in contrary to BLAST, search of sequences against profile HMMs employs position specific
scoring matrices. Penalties for mutations in conserved protein regions are higher than for mutations in
highly variable regions. This results in higher sensitivities, particularly for sequences with distant
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similarities [280]. Multiple sequence alignments and related HMMs are deposited in online repositories,
such as Pfam [281] and sequences of interests can be scanned against predictive models of multiple
databases using InterPro [282]. ToxProt, the animal toxin annotation project of UniProt, involves family
classification according to Pfam profile HMMs.
In 2017, Koua and Kuhn-Nentwig found these family annotations not to comprise all known
toxin sequences anymore and reported a high hierarchical heterogeneity in family and subfamily
organization [283]. They published new spider venom specific HMMs which we recently further
refined during our analysis of 50 spider venom gland transcriptomes. These profile HMMs enable
comprehensive peptide family classification and comparison of large datasets of toxins of different
species, thereby allowing new evolutionary insights into spider venoms. The mentioned toxin family
classification system has been proposed to complement the currently valid rational toxin nomenclature
by King et al. [119] to easily infer structural similarities of toxins [283].
3.4. Concluding Remarks on the Analysis of Venom Components
In the last years the focus of venomic studies experienced a shift from single protein analysis to
comprehensive assessment of the whole transcriptome and proteome, which is today possible with
extreme sensitivity [263,284]. While spider venom proteomes have up to date mainly been qualitatively
assessed, quantitative studies are more widespread amongst venomic analysis of other animals (e.g.,
snakes). Quantitative approaches have recently also been applied in top-down proteomics [277],
the latest protocols in proteomic venom studies. Today, top-down approaches however seem still in
their infancy and are more challenging to perform than bottom-up approaches. This is mainly due
to fewer expertise, need for protocols for sample pre-separation and expensive high-resolution mass
spectrometers, and less sophisticated data analysis tools [263,284]. Many advantages, such as gaining
information about posttranslational modifications and qualitative discrimination between closely
related proteoforms, however, predict the use of top-down approaches alongside with transcriptomic
or genomic analysis a bright future in venomics [267,271]. In addition, integration of the newest
single-molecule long-read sequencing techniques promise great improvements in de-novo read
assembly, which is challenging with data generated with today’s widely used Illumina sequencing.
Researchers working with Illumina data, should pay great attention to avoid multiplexing-based cross
contamination, which could possibly affect the conclusions of their studies.
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